#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-9	Different	_
1-2	10-16	shades	_
1-3	17-19	of	_
1-4	20-27	default	_
1-5	28-32	mode	_
1-6	33-44	disturbance	_
1-7	45-47	in	_
1-8	48-61	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-9	62-63	:	_
1-10	64-72	Subnodal	_
1-11	73-83	covariance	_
1-12	84-94	estimation	_
1-13	95-97	in	_
1-14	98-107	structure	_
1-15	108-111	and	_
1-16	112-120	function	_
1-17	121-134	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-18	135-137	is	_
1-19	138-139	a	_
1-20	140-151	devastating	_
1-21	152-158	mental	_
1-22	159-166	disease	_
1-23	167-171	with	_
1-24	172-174	an	_
1-25	175-183	apparent	_
1-26	184-194	disruption	_
1-27	195-197	in	_
1-28	198-201	the	_
1-29	202-208	highly	_
1-30	209-220	associative	_
1-31	221-228	default	_
1-32	229-233	mode	_
1-33	234-241	network	_
1-34	242-243	(	_
1-35	244-247	DMN	_
1-36	248-249	)	_
1-37	250-251	.	_

2-1	252-261	Interplay	_
2-2	262-269	between	_
2-3	270-274	this	_
2-4	275-284	canonical	_
2-5	285-292	network	_
2-6	293-296	and	_
2-7	297-303	others	_
2-8	304-312	probably	_
2-9	313-324	contributes	_
2-10	325-327	to	_
2-11	328-341	goal-directed	_
2-12	342-350	behavior	_
2-13	351-353	so	_
2-14	354-357	its	_
2-15	358-369	disturbance	_
2-16	370-372	is	_
2-17	373-374	a	_
2-18	375-384	candidate	_
2-19	385-391	neural	_
2-20	392-403	fingerprint	_
2-21	404-414	underlying	_
2-22	415-428	schizophrenia	_
2-23	429-444	psychopathology	_
2-24	445-446	.	_

3-1	447-455	Previous	_
3-2	456-464	research	_
3-3	465-468	has	_
3-4	469-477	reported	_
3-5	478-482	both	_
3-6	483-489	hyper-	_
3-7	490-493	and	_
3-8	494-511	hypo-connectivity	_
3-9	512-518	within	_
3-10	519-522	the	_
3-11	523-526	DMN	_
3-12	527-528	,	_
3-13	529-532	and	_
3-14	533-537	both	_
3-15	538-547	increased	_
3-16	548-551	and	_
3-17	552-561	decreased	_
3-18	562-565	DMN	_
3-19	566-574	coupling	_
3-20	575-579	with	_
3-21	580-583	the	_
3-22	584-595	multi-modal	_
3-23	596-604	saliency	_
3-24	605-612	network	_
3-25	613-614	(	_
3-26	615-617	SN	_
3-27	618-619	)	_
3-28	620-623	and	_
3-29	624-630	dorsal	_
3-30	631-640	attention	_
3-31	641-648	network	_
3-32	649-650	(	_
3-33	651-654	DAN	_
3-34	655-656	)	_
3-35	657-658	.	_

4-1	659-662	The	_
4-2	663-670	present	_
4-3	671-676	study	_
4-4	677-691	systematically	_
4-5	692-701	revisited	_
4-6	702-709	network	_
4-7	710-720	disruption	_
4-8	721-723	in	_
4-9	724-732	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-10	733-737	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-11	738-751	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-12	752-757	using	_
4-13	758-770	data-derived	_
4-14	771-778	network	_
4-15	779-786	atlases	_
4-16	787-790	and	_
4-17	791-803	multivariate	_
4-18	804-820	pattern-learning	_
4-19	821-831	algorithms	_
4-20	832-834	in	_
4-21	835-836	a	_
4-22	837-847	multi-site	_
4-23	848-855	dataset	_
4-24	856-857	(	_
4-25	858-863	n=325	_
4-26	864-865	)	_
4-27	866-867	.	_

5-1	868-881	Resting-state	_
5-2	882-894	fluctuations	_
5-3	895-897	in	_
5-4	898-911	unconstrained	_
5-5	912-917	brain	_
5-6	918-924	states	_
5-7	925-929	were	_
5-8	930-934	used	_
5-9	935-937	to	_
5-10	938-946	estimate	_
5-11	947-957	functional	_
5-12	958-970	connectivity	_
5-13	971-972	,	_
5-14	973-976	and	_
5-15	977-982	local	_
5-16	983-989	volume	_
5-17	990-1001	differences	_
5-18	1002-1009	between	_
5-19	1010-1021	individuals	_
5-20	1022-1026	were	_
5-21	1027-1031	used	_
5-22	1032-1034	to	_
5-23	1035-1043	estimate	_
5-24	1044-1054	structural	_
5-25	1055-1068	co-occurrence	_
5-26	1069-1075	within	_
5-27	1076-1079	and	_
5-28	1080-1087	between	_
5-29	1088-1091	the	_
5-30	1092-1095	DMN	_
5-31	1096-1097	,	_
5-32	1098-1100	SN	_
5-33	1101-1102	,	_
5-34	1103-1106	and	_
5-35	1107-1110	DAN	_
5-36	1111-1112	.	_

6-1	1113-1115	In	_
6-2	1116-1121	brain	_
6-3	1122-1131	structure	_
6-4	1132-1135	and	_
6-5	1136-1144	function	_
6-6	1145-1146	,	_
6-7	1147-1153	sparse	_
6-8	1154-1161	inverse	_
6-9	1162-1172	covariance	_
6-10	1173-1182	estimates	_
6-11	1183-1185	of	_
6-12	1186-1193	network	_
6-13	1194-1203	structure	_
6-14	1204-1208	were	_
6-15	1209-1213	used	_
6-16	1214-1216	to	_
6-17	1217-1229	characterize	_
6-18	1230-1237	healthy	_
6-19	1238-1241	and	_
6-20	1242-1250	patients	_
6-21	1251-1255	with	_
6-22	1256-1269	schizophrenia	_
6-23	1270-1276	groups	_
6-24	1277-1278	,	_
6-25	1279-1282	and	_
6-26	1283-1285	to	_
6-27	1286-1294	identify	_
6-28	1295-1308	statistically	_
6-29	1309-1320	significant	_
6-30	1321-1326	group	_
6-31	1327-1338	differences	_
6-32	1339-1340	.	_

7-1	1341-1349	Evidence	_
7-2	1350-1353	did	_
7-3	1354-1357	not	_
7-4	1358-1365	confirm	_
7-5	1366-1370	that	_
7-6	1371-1374	the	_
7-7	1375-1383	backbone	_
7-8	1384-1386	of	_
7-9	1387-1390	the	_
7-10	1391-1394	DMN	_
7-11	1395-1398	was	_
7-12	1399-1402	the	_
7-13	1403-1410	primary	_
7-14	1411-1417	driver	_
7-15	1418-1420	of	_
7-16	1421-1426	brain	_
7-17	1427-1438	dysfunction	_
7-18	1439-1441	in	_
7-19	1442-1455	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
7-20	1456-1457	.	_

8-1	1458-1465	Instead	_
8-2	1466-1467	,	_
8-3	1468-1478	functional	_
8-4	1479-1482	and	_
8-5	1483-1493	structural	_
8-6	1494-1505	aberrations	_
8-7	1506-1510	were	_
8-8	1511-1521	frequently	_
8-9	1522-1529	located	_
8-10	1530-1537	outside	_
8-11	1538-1540	of	_
8-12	1541-1544	the	_
8-13	1545-1548	DMN	_
8-14	1549-1553	core	_
8-15	1554-1555	,	_
8-16	1556-1560	such	_
8-17	1561-1563	as	_
8-18	1564-1566	in	_
8-19	1567-1570	the	_
8-20	1571-1579	anterior	_
8-21	1580-1595	temporoparietal	_
8-22	1596-1604	junction	_
8-23	1605-1608	and	_
8-24	1609-1618	precuneus	_
8-25	1619-1620	.	_

9-1	1621-1633	Additionally	_
9-2	1634-1635	,	_
9-3	1636-1646	functional	_
9-4	1647-1658	covariation	_
9-5	1659-1667	analyses	_
9-6	1668-1679	highlighted	_
9-7	1680-1693	dysfunctional	_
9-8	1694-1701	DMN-DAN	_
9-9	1702-1710	coupling	_
9-10	1711-1712	,	_
9-11	1713-1718	while	_
9-12	1719-1729	structural	_
9-13	1730-1741	covariation	_
9-14	1742-1749	results	_
9-15	1750-1761	highlighted	_
9-16	1762-1770	aberrant	_
9-17	1771-1777	DMN-SN	_
9-18	1778-1786	coupling	_
9-19	1787-1788	.	_

10-1	1789-1792	Our	_
10-2	1793-1801	findings	_
10-3	1802-1811	highlight	_
10-4	1812-1815	the	_
10-5	1816-1820	role	_
10-6	1821-1823	of	_
10-7	1824-1827	the	_
10-8	1828-1831	DMN	_
10-9	1832-1836	core	_
10-10	1837-1840	and	_
10-11	1841-1844	its	_
10-12	1845-1853	relation	_
10-13	1854-1856	to	_
10-14	1857-1866	canonical	_
10-15	1867-1875	networks	_
10-16	1876-1878	in	_
10-17	1879-1892	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-18	1893-1896	and	_
10-19	1897-1906	underline	_
10-20	1907-1910	the	_
10-21	1911-1921	importance	_
10-22	1922-1924	of	_
10-23	1925-1936	large-scale	_
10-24	1937-1943	neural	_
10-25	1944-1956	interactions	_
10-26	1957-1959	as	_
10-27	1960-1969	effective	_
10-28	1970-1980	biomarkers	_
10-29	1981-1984	and	_
10-30	1985-1995	indicators	_
10-31	1996-1998	of	_
10-32	1999-2002	how	_
10-33	2003-2005	to	_
10-34	2006-2012	tailor	_
10-35	2013-2024	psychiatric	_
10-36	2025-2029	care	_
10-37	2030-2032	to	_
10-38	2033-2039	single	_
10-39	2040-2048	patients	_
10-40	2049-2050	.	_

11-1	2051-2060	MATERIALS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-2	2061-2064	AND	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-3	2065-2072	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-4	2073-2077	Data	_
11-5	2078-2087	resources	_
11-6	2088-2092	This	_
11-7	2093-2098	study	_
11-8	2099-2109	considered	_
11-9	2110-2118	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
11-10	2119-2128	resonance	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
11-11	2129-2136	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
11-12	2137-2138	(	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
11-13	2139-2142	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
11-14	2143-2144	)	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
11-15	2145-2149	data	_
11-16	2150-2154	from	_
11-17	2155-2156	5	_
11-18	2157-2166	different	_
11-19	2167-2177	population	_
11-20	2178-2185	samples	_
11-21	2186-2194	acquired	_
11-22	2195-2197	in	_
11-23	2198-2204	Europe	_
11-24	2205-2208	and	_
11-25	2209-2212	USA	_
11-26	2213-2214	:	_
11-27	2215-2221	Aachen	_
11-28	2222-2223	,	_
11-29	2224-2234	Goettingen	_
11-30	2235-2236	,	_
11-31	2237-2247	Groeningen	_
11-32	2248-2249	,	_
11-33	2250-2255	Lille	_
11-34	2256-2257	,	_
11-35	2258-2261	and	_
11-36	2262-2267	COBRE	_
11-37	2268-2269	.	_

12-1	2270-2283	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
12-2	2284-2294	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
12-3	2295-2307	connectivity	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
12-4	2308-2309	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
12-5	2310-2314	RSFC	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
12-6	2315-2316	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalCapacityRatingScale
12-7	2317-2320	and	_
12-8	2321-2332	voxel-based	_
12-9	2333-2345	morphometric	_
12-10	2346-2347	(	http://maven.renci.org/NeuroBridge/neurobridge#Thing
12-11	2348-2351	VBM	_
12-12	2352-2353	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
12-13	2354-2358	data	_
12-14	2359-2363	were	_
12-15	2364-2373	collected	_
12-16	2374-2378	from	_
12-17	2379-2380	a	_
12-18	2381-2386	total	_
12-19	2387-2389	of	_
12-20	2390-2393	482	_
12-21	2394-2406	participants	_
12-22	2407-2408	,	_
12-23	2409-2412	241	_
12-24	2413-2421	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-25	2422-2426	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-26	2427-2440	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-27	2441-2444	and	_
12-28	2445-2448	241	_
12-29	2449-2456	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-30	2457-2465	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-31	2466-2467	.	_

13-1	2468-2473	Given	_
13-2	2474-2477	the	_
13-3	2478-2485	present	_
13-4	2486-2490	goal	_
13-5	2491-2493	to	_
13-6	2494-2502	directly	_
13-7	2503-2510	compare	_
13-8	2511-2521	functional	_
13-9	2522-2527	brain	_
13-10	2528-2538	recordings	_
13-11	2539-2542	and	_
13-12	2543-2553	structural	_
13-13	2554-2559	brain	_
13-14	2560-2565	scans	_
13-15	2566-2567	,	_
13-16	2568-2570	we	_
13-17	2571-2578	further	_
13-18	2579-2589	considered	_
13-19	2590-2594	only	_
13-20	2595-2600	those	_
13-21	2601-2613	participants	_
13-22	2614-2617	who	_
13-23	2618-2626	provided	_
13-24	2627-2631	both	_
13-25	2632-2636	RSFC	_
13-26	2637-2640	and	_
13-27	2641-2644	VBM	_
13-28	2645-2647	in	_
13-29	2648-2651	the	_
13-30	2652-2660	database	_
13-31	2661-2662	.	_

14-1	2663-2668	These	_
14-2	2669-2676	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
14-3	2677-2680	and	_
14-4	2681-2688	disease	http://maven.renci.org/NeuroBridge/neurobridge#DiseaseDiagnosis
14-5	2689-2695	groups	_
14-6	2696-2697	(	_
14-7	2698-2703	n=325	_
14-8	2704-2705	)	_
14-9	2706-2710	were	_
14-10	2711-2718	matched	_
14-11	2719-2722	for	_
14-12	2723-2726	age	_
14-13	2727-2733	within	_
14-14	2734-2737	and	_
14-15	2738-2744	across	_
14-16	2745-2750	sites	_
14-17	2751-2752	(	_
14-18	2753-2756	see	_
14-19	2757-2770	Supplementary	_
14-20	2771-2776	Table	_
14-21	2777-2778	1	_
14-22	2779-2782	for	_
14-23	2783-2790	details	_
14-24	2791-2792	)	_
14-25	2793-2794	.	_

15-1	2795-2797	No	_
15-2	2798-2809	participant	_
15-3	2810-2812	in	_
15-4	2813-2816	the	_
15-5	2817-2824	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
15-6	2825-2830	group	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
15-7	2831-2834	had	_
15-8	2835-2836	a	_
15-9	2837-2843	record	_
15-10	2844-2846	of	_
15-11	2847-2859	neurological	_
15-12	2860-2862	or	_
15-13	2863-2874	psychiatric	_
15-14	2875-2884	disorders	_
15-15	2885-2886	.	_

16-1	2887-2891	Each	_
16-2	2892-2903	participant	_
16-3	2904-2906	in	_
16-4	2907-2910	the	_
16-5	2911-2924	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
16-6	2925-2930	group	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
16-7	2931-2934	had	_
16-8	2935-2939	been	_
16-9	2940-2949	diagnosed	_
16-10	2950-2952	by	_
16-11	2953-2954	a	_
16-12	2955-2970	board-certified	_
16-13	2971-2983	psychiatrist	_
16-14	2984-2986	in	_
16-15	2987-2997	accordance	_
16-16	2998-3002	with	_
16-17	3003-3006	the	_
16-18	3007-3015	clinical	_
16-19	3016-3024	criteria	_
16-20	3025-3027	of	_
16-21	3028-3031	the	_
16-22	3032-3045	International	_
16-23	3046-3060	Classification	_
16-24	3061-3063	of	_
16-25	3064-3072	Diseases	_
16-26	3073-3074	(	_
16-27	3075-3081	ICD-10	_
16-28	3082-3083	)	_
16-29	3084-3086	or	_
16-30	3087-3090	the	_
16-31	3091-3101	Diagnostic	_
16-32	3102-3105	and	_
16-33	3106-3117	Statistical	_
16-34	3118-3124	Manual	_
16-35	3125-3127	of	_
16-36	3128-3134	Mental	_
16-37	3135-3144	Disorders	_
16-38	3145-3146	(	_
16-39	3147-3156	DSM-IV-TR	_
16-40	3157-3158	)	_
16-41	3159-3160	.	_

17-1	3161-3164	All	_
17-2	3165-3176	acquisition	_
17-3	3177-3182	sites	_
17-4	3183-3187	used	_
17-5	3188-3190	3T	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
17-6	3191-3194	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
17-7	3195-3203	scanners	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
17-8	3204-3205	(	_
17-9	3206-3209	see	_
17-10	3210-3223	Supplementary	_
17-11	3224-3229	Table	_
17-12	3230-3231	2	_
17-13	3232-3235	for	_
17-14	3236-3243	details	_
17-15	3244-3245	)	_
17-16	3246-3247	.	_

18-1	3248-3251	For	_
18-2	3252-3255	the	_
18-3	3256-3267	acquisition	_
18-4	3268-3270	of	_
18-5	3271-3281	functional	_
18-6	3282-3287	brain	_
18-7	3288-3292	maps	_
18-8	3293-3294	(	_
18-9	3295-3299	i.e.	_
18-10	3300-3301	,	_
18-11	3302-3306	RSFC	_
18-12	3307-3308	)	_
18-13	3309-3310	,	_
18-14	3311-3315	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
18-15	3316-3321	scans	_
18-16	3322-3324	of	_
18-17	3325-3353	blood-oxygen-level-dependent	_
18-18	3354-3355	(	_
18-19	3356-3360	BOLD	_
18-20	3361-3362	)	_
18-21	3363-3369	signal	_
18-22	3370-3374	were	_
18-23	3375-3383	recorded	_
18-24	3384-3388	from	_
18-25	3389-3392	the	_
18-26	3393-3405	participants	_
18-27	3406-3409	who	_
18-28	3410-3414	were	_
18-29	3415-3425	instructed	_
18-30	3426-3428	to	_
18-31	3429-3432	lie	_
18-32	3433-3438	still	_
18-33	3439-3445	during	_
18-34	3446-3449	the	_
18-35	3450-3458	scanning	_
18-36	3459-3466	session	_
18-37	3467-3470	and	_
18-38	3471-3473	to	_
18-39	3474-3477	let	_
18-40	3478-3481	the	_
18-41	3482-3486	mind	_
18-42	3487-3493	wander	_
18-43	3494-3495	.	_

19-1	3496-3497	A	_
19-2	3498-3507	post-scan	_
19-3	3508-3517	interview	_
19-4	3518-3527	confirmed	_
19-5	3528-3532	that	_
19-6	3533-3545	participants	_
19-7	3546-3553	adhered	_
19-8	3554-3556	to	_
19-9	3557-3562	these	_
19-10	3563-3575	instructions	_
19-11	3576-3579	and	_
19-12	3580-3583	did	_
19-13	3584-3587	not	_
19-14	3588-3592	fall	_
19-15	3593-3599	asleep	_
19-16	3600-3601	.	_

20-1	3602-3605	For	_
20-2	3606-3609	the	_
20-3	3610-3621	acquisition	_
20-4	3622-3624	of	_
20-5	3625-3635	structural	_
20-6	3636-3641	brain	_
20-7	3642-3646	maps	_
20-8	3647-3648	(	_
20-9	3649-3653	i.e.	_
20-10	3654-3655	,	_
20-11	3656-3659	VBM	_
20-12	3660-3661	)	_
20-13	3662-3663	,	_
20-14	3664-3666	3D	_
20-15	3667-3669	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
20-16	3670-3673	MRI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
20-17	3674-3679	scans	_
20-18	3680-3684	were	_
20-19	3685-3693	recorded	_
20-20	3694-3698	from	_
20-21	3699-3703	each	_
20-22	3704-3715	participant	_
20-23	3716-3717	.	_

21-1	3718-3721	All	_
21-2	3722-3734	participants	_
21-3	3735-3739	gave	_
21-4	3740-3747	written	_
21-5	3748-3756	informed	_
21-6	3757-3764	consent	_
21-7	3765-3767	to	_
21-8	3768-3779	participate	_
21-9	3780-3782	in	_
21-10	3783-3786	the	_
21-11	3787-3792	study	_
21-12	3793-3794	,	_
21-13	3795-3800	which	_
21-14	3801-3804	was	_
21-15	3805-3813	approved	_
21-16	3814-3816	by	_
21-17	3817-3820	the	_
21-18	3821-3827	ethics	_
21-19	3828-3837	committee	_
21-20	3838-3840	of	_
21-21	3841-3844	the	_
21-22	3845-3849	RWTH	_
21-23	3850-3856	Aachen	_
21-24	3857-3867	University	_
21-25	3868-3869	,	_
21-26	3870-3877	Germany	_
21-27	3878-3879	.	_

22-1	3880-3884	Note	_
22-2	3885-3889	that	_
22-3	3890-3893	all	_
22-4	3894-3904	phenotypic	_
22-5	3905-3916	information	_
22-6	3917-3920	has	_
22-7	3921-3925	been	_
22-8	3926-3936	anonymized	_
22-9	3937-3940	for	_
22-10	3941-3951	tabulation	_
22-11	3952-3953	.	_

23-1	3954-3959	Brain	_
23-2	3960-3968	function	_
23-3	3969-3970	:	_
23-4	3971-3984	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-5	3985-3989	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-6	3990-3992	To	_
23-7	3993-4000	measure	_
23-8	4001-4011	functional	_
23-9	4012-4020	activity	_
23-10	4021-4023	of	_
23-11	4024-4029	brain	_
23-12	4030-4037	regions	_
23-13	4038-4039	,	_
23-14	4040-4042	we	_
23-15	4043-4051	analyzed	_
23-16	4052-4065	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-17	4066-4069	EPI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-18	4070-4071	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-19	4072-4083	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-20	4084-4091	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-21	4092-4093	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-22	4094-4099	scans	_
23-23	4100-4104	from	_
23-24	4105-4113	standard	_
23-25	4114-4118	BOLD	_
23-26	4119-4131	acquisitions	_
23-27	4132-4133	(	_
23-28	4134-4137	see	_
23-29	4138-4151	Supplementary	_
23-30	4152-4157	Table	_
23-31	4158-4159	2	_
23-32	4160-4163	for	_
23-33	4164-4171	details	_
23-34	4172-4173	)	_
23-35	4174-4175	.	_

24-1	4176-4179	The	_
24-2	4180-4193	preprocessing	_
24-3	4194-4197	was	_
24-4	4198-4207	performed	_
24-5	4208-4210	in	_
24-6	4211-4215	SPM8	_
24-7	4216-4217	(	_
24-8	4218-4229	Statistical	_
24-9	4230-4240	Parametric	_
24-10	4241-4248	Mapping	_
24-11	4249-4250	,	_
24-12	4251-4259	Wellcome	_
24-13	4260-4270	Department	_
24-14	4271-4273	of	_
24-15	4274-4281	Imaging	_
24-16	4282-4294	Neuroscience	_
24-17	4295-4296	,	_
24-18	4297-4303	London	_
24-19	4304-4305	,	_
24-20	4306-4308	UK	_
24-21	4309-4310	,	_
24-22	4311-4315	http	_
24-23	4316-4317	:	_
24-24	4318-4346	//www.fil.ion.ucl.ac.uk/spm/	_
24-25	4347-4348	)	_
24-26	4349-4352	run	_
24-27	4353-4358	under	_
24-28	4359-4365	MATLAB	_
24-29	4366-4372	R2014a	_
24-30	4373-4374	(	_
24-31	4375-4384	Mathworks	_
24-32	4385-4386	,	_
24-33	4387-4393	Natick	_
24-34	4394-4395	,	_
24-35	4396-4398	MA	_
24-36	4399-4400	,	_
24-37	4401-4403	US	_
24-38	4404-4405	)	_
24-39	4406-4407	.	_

25-1	4408-4411	The	_
25-2	4412-4417	first	_
25-3	4418-4419	4	_
25-4	4420-4425	brain	_
25-5	4426-4431	scans	_
25-6	4432-4436	were	_
25-7	4437-4446	discarded	_
25-8	4447-4449	to	_
25-9	4450-4455	allow	_
25-10	4456-4459	for	_
25-11	4460-4468	magnetic	_
25-12	4469-4474	field	_
25-13	4475-4485	saturation	_
25-14	4486-4487	.	_

26-1	4488-4491	The	_
26-2	4492-4495	EPI	_
26-3	4496-4502	images	_
26-4	4503-4507	were	_
26-5	4508-4517	corrected	_
26-6	4518-4521	for	_
26-7	4522-4526	head	_
26-8	4527-4535	movement	_
26-9	4536-4538	by	_
26-10	4539-4545	affine	_
26-11	4546-4558	registration	_
26-12	4559-4564	using	_
26-13	4565-4566	a	_
26-14	4567-4573	2-pass	_
26-15	4574-4583	procedure	_
26-16	4584-4585	.	_

27-1	4586-4588	To	_
27-2	4589-4596	further	_
27-3	4597-4603	reduce	_
27-4	4604-4612	spurious	_
27-5	4613-4625	correlations	_
27-6	4626-4633	induced	_
27-7	4634-4636	by	_
27-8	4637-4643	motion	_
27-9	4644-4645	,	_
27-10	4646-4654	variance	_
27-11	4655-4659	that	_
27-12	4660-4665	could	_
27-13	4666-4668	be	_
27-14	4669-4678	explained	_
27-15	4679-4681	by	_
27-16	4682-4685	the	_
27-17	4686-4690	head	_
27-18	4691-4697	motion	_
27-19	4698-4701	was	_
27-20	4702-4709	removed	_
27-21	4710-4714	from	_
27-22	4715-4719	each	_
27-23	4720-4725	voxel	_
27-24	4726-4727	â€™	_
27-25	4728-4729	s	_
27-26	4730-4734	time	_
27-27	4735-4741	series	_
27-28	4742-4743	.	_

28-1	4744-4746	In	_
28-2	4747-4757	particular	_
28-3	4758-4759	,	_
28-4	4760-4762	in	_
28-5	4763-4772	adherence	_
28-6	4773-4775	to	_
28-7	4776-4786	previously	_
28-8	4787-4796	published	_
28-9	4797-4808	evaluations	_
28-10	4809-4810	,	_
28-11	4811-4813	we	_
28-12	4814-4821	removed	_
28-13	4822-4830	nuisance	_
28-14	4831-4838	signals	_
28-15	4839-4848	according	_
28-16	4849-4851	to	_
28-17	4852-4853	:	_
28-18	4854-4855	a	_
28-19	4856-4857	)	_
28-20	4858-4861	the	_
28-21	4862-4863	6	_
28-22	4864-4870	motion	_
28-23	4871-4881	parameters	_
28-24	4882-4889	derived	_
28-25	4890-4894	from	_
28-26	4895-4898	the	_
28-27	4899-4904	image	_
28-28	4905-4916	realignment	_
28-29	4917-4918	,	_
28-30	4919-4920	b	_
28-31	4921-4922	)	_
28-32	4923-4928	their	_
28-33	4929-4934	first	_
28-34	4935-4946	derivatives	_
28-35	4947-4948	,	_
28-36	4949-4952	and	_
28-37	4953-4954	c	_
28-38	4955-4956	)	_
28-39	4957-4960	the	_
28-40	4961-4971	respective	_
28-41	4972-4979	squared	_
28-42	4980-4985	terms	_
28-43	4986-4987	(	_
28-44	4988-4992	i.e.	_
28-45	4993-4994	,	_
28-46	4995-4997	24	_
28-47	4998-5007	parameter	_
28-48	5008-5018	regression	_
28-49	5019-5020	)	_
28-50	5021-5022	.	_

29-1	5023-5028	These	_
29-2	5029-5040	corrections	_
29-3	5041-5045	have	_
29-4	5046-5050	been	_
29-5	5051-5056	shown	_
29-6	5057-5059	to	_
29-7	5060-5068	increase	_
29-8	5069-5080	specificity	_
29-9	5081-5084	and	_
29-10	5085-5096	sensitivity	_
29-11	5097-5099	of	_
29-12	5100-5110	functional	_
29-13	5111-5123	connectivity	_
29-14	5124-5132	analyses	_
29-15	5133-5136	and	_
29-16	5137-5139	to	_
29-17	5140-5146	detect	_
29-18	5147-5152	valid	_
29-19	5153-5159	signal	_
29-20	5160-5171	correlation	_
29-21	5172-5174	at	_
29-22	5175-5179	rest	_
29-23	5180-5181	.	_

30-1	5182-5188	Motion	_
30-2	5189-5199	correction	_
30-3	5200-5203	was	_
30-4	5204-5211	applied	_
30-5	5212-5214	in	_
30-6	5215-5218	all	_
30-7	5219-5227	analyses	_
30-8	5228-5229	.	_

31-1	5230-5232	We	_
31-2	5233-5236	did	_
31-3	5237-5240	not	_
31-4	5241-5248	perform	_
31-5	5249-5255	global	_
31-6	5256-5262	signal	_
31-7	5263-5273	regression	_
31-8	5274-5275	.	_

32-1	5276-5283	Finally	_
32-2	5284-5285	,	_
32-3	5286-5289	the	_
32-4	5290-5296	signal	_
32-5	5297-5301	time	_
32-6	5302-5308	series	_
32-7	5309-5313	were	_
32-8	5314-5323	band-pass	_
32-9	5324-5332	filtered	_
32-10	5333-5335	to	_
32-11	5336-5344	preserve	_
32-12	5345-5356	frequencies	_
32-13	5357-5364	between	_
32-14	5365-5369	0.01	_
32-15	5370-5373	and	_
32-16	5374-5378	0.08	_
32-17	5379-5381	Hz	_
32-18	5382-5387	which	_
32-19	5388-5392	have	_
32-20	5393-5403	previously	_
32-21	5404-5408	been	_
32-22	5409-5419	associated	_
32-23	5420-5424	with	_
32-24	5425-5437	fluctuations	_
32-25	5438-5440	of	_
32-26	5441-5449	neuronal	_
32-27	5450-5458	activity	_
32-28	5459-5460	,	_
32-29	5461-5464	and	_
32-30	5465-5468	are	_
32-31	5469-5474	least	_
32-32	5475-5483	impacted	_
32-33	5484-5486	by	_
32-34	5487-5500	physiological	_
32-35	5501-5510	artifacts	_
32-36	5511-5515	such	_
32-37	5516-5518	as	_
32-38	5519-5524	heart	_
32-39	5525-5529	rate	_
32-40	5530-5533	and	_
32-41	5534-5546	respirations	_
32-42	5547-5548	.	_

33-1	5549-5554	Brain	_
33-2	5555-5564	structure	_
33-3	5565-5566	:	_
33-4	5567-5578	Voxel-based	_
33-5	5579-5590	morphometry	_
33-6	5591-5594	MRI	_
33-7	5595-5597	To	_
33-8	5598-5605	measure	_
33-9	5606-5609	the	_
33-10	5610-5615	local	_
33-11	5616-5621	brain	_
33-12	5622-5628	volume	_
33-13	5629-5635	across	_
33-14	5636-5647	individuals	_
33-15	5648-5649	,	_
33-16	5650-5651	a	_
33-17	5652-5667	high-resolution	_
33-18	5668-5678	anatomical	_
33-19	5679-5684	image	_
33-20	5685-5688	was	_
33-21	5689-5697	acquired	_
33-22	5698-5702	from	_
33-23	5703-5707	each	_
33-24	5708-5719	participant	_
33-25	5720-5725	using	_
33-26	5726-5738	conventional	_
33-27	5739-5747	scanning	_
33-28	5748-5757	sequences	_
33-29	5758-5759	.	_

34-1	5760-5770	Anatomical	_
34-2	5771-5776	scans	_
34-3	5777-5781	were	_
34-4	5782-5794	preprocessed	_
34-5	5795-5799	with	_
34-6	5800-5803	the	_
34-7	5804-5808	VBM8	_
34-8	5809-5816	toolbox	_
34-9	5817-5818	(	_
34-10	5819-5824	https	_
34-11	5825-5826	:	_
34-12	5827-5854	//dbm.neuro.uni-jena.de/vbm	_
34-13	5855-5856	)	_
34-14	5857-5859	in	_
34-15	5860-5864	SPM8	_
34-16	5865-5870	using	_
34-17	5871-5879	standard	_
34-18	5880-5888	settings	_
34-19	5889-5890	(	_
34-20	5891-5897	DARTEL	_
34-21	5898-5911	normalization	_
34-22	5912-5914	to	_
34-23	5915-5918	the	_
34-24	5919-5927	ICBM-152	_
34-25	5928-5936	template	_
34-26	5937-5938	,	_
34-27	5939-5945	affine	_
34-28	5946-5949	and	_
34-29	5950-5960	non-linear	_
34-30	5961-5968	spatial	_
34-31	5969-5982	normalization	_
34-32	5983-5984	)	_
34-33	5985-5986	.	_

35-1	5987-5993	Within	_
35-2	5994-5995	a	_
35-3	5996-6003	unified	_
35-4	6004-6016	segmentation	_
35-5	6017-6022	model	_
35-6	6023-6024	,	_
35-7	6025-6028	the	_
35-8	6029-6034	brain	_
35-9	6035-6040	scans	_
35-10	6041-6045	were	_
35-11	6046-6055	corrected	_
35-12	6056-6059	for	_
35-13	6060-6070	bias-field	_
35-14	6071-6086	inhomogeneities	_
35-15	6087-6088	.	_

36-1	6089-6092	The	_
36-2	6093-6098	brain	_
36-3	6099-6105	tissue	_
36-4	6106-6109	was	_
36-5	6110-6119	segmented	_
36-6	6120-6124	into	_
36-7	6125-6129	gray	_
36-8	6130-6136	matter	_
36-9	6137-6138	,	_
36-10	6139-6144	white	_
36-11	6145-6151	matter	_
36-12	6152-6153	,	_
36-13	6154-6157	and	_
36-14	6158-6171	cerebrospinal	_
36-15	6172-6177	fluid	_
36-16	6178-6179	,	_
36-17	6180-6185	while	_
36-18	6186-6195	adjusting	_
36-19	6196-6199	for	_
36-20	6200-6207	partial	_
36-21	6208-6214	volume	_
36-22	6215-6222	effects	_
36-23	6223-6224	.	_

37-1	6225-6227	We	_
37-2	6228-6237	performed	_
37-3	6238-6247	nonlinear	_
37-4	6248-6258	modulation	_
37-5	6259-6261	of	_
37-6	6262-6271	segmented	_
37-7	6272-6278	images	_
37-8	6279-6281	to	_
37-9	6282-6289	account	_
37-10	6290-6293	for	_
37-11	6294-6297	the	_
37-12	6298-6304	amount	_
37-13	6305-6307	of	_
37-14	6308-6317	expansion	_
37-15	6318-6321	and	_
37-16	6322-6333	contraction	_
37-17	6334-6341	applied	_
37-18	6342-6348	during	_
37-19	6349-6362	normalization	_
37-20	6363-6368	using	_
37-21	6369-6372	the	_
37-22	6373-6382	nonlinear	_
37-23	6383-6387	only	_
37-24	6388-6398	modulation	_
37-25	6399-6407	function	_
37-26	6408-6414	within	_
37-27	6415-6418	the	_
37-28	6419-6423	VBM8	_
37-29	6424-6431	toolbox	_
37-30	6432-6433	.	_

38-1	6434-6437	The	_
38-2	6438-6445	ensuing	_
38-3	6446-6454	adjusted	_
38-4	6455-6461	volume	_
38-5	6462-6474	measurements	_
38-6	6475-6486	represented	_
38-7	6487-6490	the	_
38-8	6491-6497	amount	_
38-9	6498-6500	of	_
38-10	6501-6505	gray	_
38-11	6506-6512	matter	_
38-12	6513-6522	corrected	_
38-13	6523-6526	for	_
38-14	6527-6537	individual	_
38-15	6538-6543	brain	_
38-16	6544-6549	sizes	_
38-17	6550-6551	.	_

39-1	6552-6559	Regions	_
39-2	6560-6562	of	_
39-3	6563-6571	interest	_
39-4	6572-6575	The	_
39-5	6576-6579	DMN	_
39-6	6580-6582	is	_
39-7	6583-6594	essentially	_
39-8	6595-6603	composed	_
39-9	6604-6606	of	_
39-10	6607-6611	four	_
39-11	6612-6617	areas	_
39-12	6618-6619	(	_
39-13	6620-6625	which	_
39-14	6626-6628	we	_
39-15	6629-6634	refer	_
39-16	6635-6637	to	_
39-17	6638-6648	throughout	_
39-18	6649-6651	as	_
39-19	6652-6659	network	_
39-20	6660-6665	nodes	_
39-21	6666-6667	)	_
39-22	6668-6669	,	_
39-23	6670-6679	including	_
39-24	6680-6683	the	_
39-25	6684-6695	dorsomedial	_
39-26	6696-6706	prefrontal	_
39-27	6707-6713	cortex	_
39-28	6714-6715	(	_
39-29	6716-6721	DMPFC	_
39-30	6722-6723	)	_
39-31	6724-6725	,	_
39-32	6726-6729	the	_
39-33	6730-6743	posteromedial	_
39-34	6744-6750	cortex	_
39-35	6751-6752	(	_
39-36	6753-6756	PMC	_
39-37	6757-6758	)	_
39-38	6759-6760	,	_
39-39	6761-6763	as	_
39-40	6764-6768	well	_
39-41	6769-6771	as	_
39-42	6772-6775	the	_
39-43	6776-6780	left	_
39-44	6781-6784	and	_
39-45	6785-6790	right	_
39-46	6791-6806	temporoparietal	_
39-47	6807-6816	junctions	_
39-48	6817-6818	(	_
39-49	6819-6823	TPJs	_
39-50	6824-6825	)	_
39-51	6826-6827	.	_

40-1	6828-6830	We	_
40-2	6831-6835	note	_
40-3	6836-6840	that	_
40-4	6841-6844	the	_
40-5	6845-6851	common	_
40-6	6852-6860	approach	_
40-7	6861-6863	is	_
40-8	6864-6866	to	_
40-9	6867-6874	examine	_
40-10	6875-6878	the	_
40-11	6879-6882	DMN	_
40-12	6883-6887	with	_
40-13	6888-6893	these	_
40-14	6894-6899	nodes	_
40-15	6900-6902	as	_
40-16	6903-6910	targets	_
40-17	6911-6913	of	_
40-18	6914-6927	investigation	_
40-19	6928-6929	,	_
40-20	6930-6938	assuming	_
40-21	6939-6943	that	_
40-22	6944-6947	the	_
40-23	6948-6953	nodes	_
40-24	6954-6956	of	_
40-25	6957-6960	the	_
40-26	6961-6964	DMN	_
40-27	6965-6968	are	_
40-28	6969-6981	functionally	_
40-29	6982-6993	homogeneous	_
40-30	6994-6995	.	_

41-1	6996-7008	Nevertheless	_
41-2	7009-7010	,	_
41-3	7011-7014	the	_
41-4	7015-7025	functional	_
41-5	7026-7038	contribution	_
41-6	7039-7041	of	_
41-7	7042-7046	each	_
41-8	7047-7057	individual	_
41-9	7058-7062	node	_
41-10	7063-7065	to	_
41-11	7066-7069	the	_
41-12	7070-7077	various	_
41-13	7078-7086	abstract	_
41-14	7087-7096	cognitive	_
41-15	7097-7106	processes	_
41-16	7107-7117	maintained	_
41-17	7118-7120	by	_
41-18	7121-7124	the	_
41-19	7125-7132	overall	_
41-20	7133-7140	network	_
41-21	7141-7148	remains	_
41-22	7149-7161	inconclusive	_
41-23	7162-7163	(	_
41-24	7164-7166	cf	_
41-25	7167-7168	.	_
41-26	7169-7170	)	_
41-27	7171-7172	.	_

42-1	7173-7179	Indeed	_
42-2	7180-7181	,	_
42-3	7182-7187	there	_
42-4	7188-7190	is	_
42-5	7191-7197	recent	_
42-6	7198-7207	empirical	_
42-7	7208-7216	evidence	_
42-8	7217-7221	that	_
42-9	7222-7225	the	_
42-10	7226-7236	individual	_
42-11	7237-7242	nodes	_
42-12	7243-7245	of	_
42-13	7246-7249	the	_
42-14	7250-7253	DMN	_
42-15	7254-7263	segregate	_
42-16	7264-7268	into	_
42-17	7269-7277	distinct	_
42-18	7278-7286	subnodes	_
42-19	7287-7288	.	_

43-1	7289-7294	These	_
43-2	7295-7299	data	_
43-3	7300-7307	support	_
43-4	7308-7311	the	_
43-5	7312-7318	notion	_
43-6	7319-7323	that	_
43-7	7324-7341	neurobiologically	_
43-8	7342-7352	meaningful	_
43-9	7353-7365	subdivisions	_
43-10	7366-7372	within	_
43-11	7373-7377	each	_
43-12	7378-7382	node	_
43-13	7383-7385	of	_
43-14	7386-7389	the	_
43-15	7390-7393	DMN	_
43-16	7394-7399	exist	_
43-17	7400-7403	and	_
43-18	7404-7409	could	_
43-19	7410-7412	be	_
43-20	7413-7423	profitably	_
43-21	7424-7431	studied	_
43-22	7432-7434	in	_
43-23	7435-7438	the	_
43-24	7439-7446	context	_
43-25	7447-7449	of	_
43-26	7450-7454	both	_
43-27	7455-7462	healthy	_
43-28	7463-7466	and	_
43-29	7467-7475	abnormal	_
43-30	7476-7481	human	_
43-31	7482-7487	brain	_
43-32	7488-7496	function	_
43-33	7497-7498	.	_

44-1	7499-7505	Indeed	_
44-2	7506-7507	,	_
44-3	7508-7510	in	_
44-4	7511-7512	a	_
44-5	7513-7519	series	_
44-6	7520-7522	of	_
44-7	7523-7529	recent	_
44-8	7530-7541	data-driven	_
44-9	7542-7549	studies	_
44-10	7550-7551	,	_
44-11	7552-7555	the	_
44-12	7556-7566	individual	_
44-13	7567-7572	nodes	_
44-14	7573-7575	of	_
44-15	7576-7579	the	_
44-16	7580-7583	DMN	_
44-17	7584-7588	have	_
44-18	7589-7593	been	_
44-19	7594-7604	segregated	_
44-20	7605-7609	into	_
44-21	7610-7618	distinct	_
44-22	7619-7627	subnodes	_
44-23	7628-7633	based	_
44-24	7634-7636	on	_
44-25	7637-7642	local	_
44-26	7643-7654	differences	_
44-27	7655-7657	in	_
44-28	7658-7668	functional	_
44-29	7669-7680	interaction	_
44-30	7681-7689	patterns	_
44-31	7690-7694	with	_
44-32	7695-7698	the	_
44-33	7699-7703	rest	_
44-34	7704-7706	of	_
44-35	7707-7710	the	_
44-36	7711-7716	brain	_
44-37	7717-7718	,	_
44-38	7719-7721	an	_
44-39	7722-7733	established	_
44-40	7734-7742	analysis	_
44-41	7743-7752	technique	_
44-42	7753-7759	called	_
44-43	7760-7778	connectivity-based	_
44-44	7779-7791	parcellation	_
44-45	7792-7793	.	_

45-1	7794-7798	This	_
45-2	7799-7808	technique	_
45-3	7809-7816	assumes	_
45-4	7817-7821	that	_
45-5	7822-7823	a	_
45-6	7824-7827	ROI	_
45-7	7828-7831	may	_
45-8	7832-7834	be	_
45-9	7835-7842	divided	_
45-10	7843-7847	into	_
45-11	7848-7856	distinct	_
45-12	7857-7867	subregions	_
45-13	7868-7873	based	_
45-14	7874-7876	on	_
45-15	7877-7880	its	_
45-16	7881-7892	whole-brain	_
45-17	7893-7905	connectivity	_
45-18	7906-7914	profiles	_
45-19	7915-7916	.	_

46-1	7917-7920	For	_
46-2	7921-7925	each	_
46-3	7926-7936	considered	_
46-4	7937-7940	DMN	_
46-5	7941-7945	node	_
46-6	7946-7947	,	_
46-7	7948-7966	connectivity-based	_
46-8	7967-7979	parcellation	_
46-9	7980-7983	has	_
46-10	7984-7994	previously	_
46-11	7995-8007	demonstrated	_
46-12	8008-8009	a	_
46-13	8010-8021	subdivision	_
46-14	8022-8024	of	_
46-15	8025-8028	the	_
46-16	8029-8032	ROI	_
46-17	8033-8037	into	_
46-18	8038-8045	cluster	_
46-19	8046-8050	with	_
46-20	8051-8064	topographical	_
46-21	8065-8073	boundary	_
46-22	8074-8085	definitions	_
46-23	8086-8091	which	_
46-24	8092-8095	can	_
46-25	8096-8098	be	_
46-26	8099-8105	reused	_
46-27	8106-8108	in	_
46-28	8109-8114	other	_
46-29	8115-8122	studies	_
46-30	8123-8124	.	_

47-1	8125-8130	First	_
47-2	8131-8132	,	_
47-3	8133-8135	we	_
47-4	8136-8140	used	_
47-5	8141-8144	the	_
47-6	8145-8148	DMN	_
47-7	8149-8154	atlas	_
47-8	8155-8159	with	_
47-9	8160-8163	the	_
47-10	8164-8169	DMPFC	_
47-11	8170-8171	,	_
47-12	8172-8175	PMC	_
47-13	8176-8177	,	_
47-14	8178-8181	and	_
47-15	8182-8186	both	_
47-16	8187-8191	TPJs	_
47-17	8192-8194	as	_
47-18	8195-8204	composite	_
47-19	8205-8210	nodes	_
47-20	8211-8212	(	_
47-21	8213-8214	4	_
47-22	8215-8219	ROIs	_
47-23	8220-8221	)	_
47-24	8222-8223	,	_
47-25	8224-8228	each	_
47-26	8229-8240	recombining	_
47-27	8241-8244	its	_
47-28	8245-8256	constituent	_
47-29	8257-8265	subnodes	_
47-30	8266-8267	(	_
47-31	8268-8271	Fig	_
47-32	8272-8273	.	_

48-1	8274-8277	1.A	_
48-2	8278-8279	.	_
48-3	8280-8281	)	_
48-4	8282-8283	.	_

49-1	8284-8287	The	_
49-2	8288-8299	covariation	_
49-3	8300-8308	analyses	_
49-4	8309-8314	based	_
49-5	8315-8317	on	_
49-6	8318-8322	this	_
49-7	8323-8326	ROI	_
49-8	8327-8330	set	_
49-9	8331-8339	examined	_
49-10	8340-8343	the	_
49-11	8344-8347	DMN	_
49-12	8348-8350	at	_
49-13	8351-8354	the	_
49-14	8355-8367	conventional	_
49-15	8368-8373	level	_
49-16	8374-8376	of	_
49-17	8377-8388	granularity	_
49-18	8389-8390	:	_
49-19	8391-8395	that	_
49-20	8396-8398	is	_
49-21	8399-8401	of	_
49-22	8402-8409	network	_
49-23	8410-8415	nodes	_
49-24	8416-8417	.	_

50-1	8418-8422	This	_
50-2	8423-8429	served	_
50-3	8430-8432	as	_
50-4	8433-8434	a	_
50-5	8435-8440	point	_
50-6	8441-8443	of	_
50-7	8444-8454	comparison	_
50-8	8455-8458	for	_
50-9	8459-8462	how	_
50-10	8463-8467	this	_
50-11	8468-8473	major	_
50-12	8474-8479	brain	_
50-13	8480-8487	network	_
50-14	8488-8491	has	_
50-15	8492-8496	most	_
50-16	8497-8507	frequently	_
50-17	8508-8512	been	_
50-18	8513-8520	studied	_
50-19	8521-8523	in	_
50-20	8524-8532	previous	_
50-21	8533-8546	brain-imaging	_
50-22	8547-8555	research	_
50-23	8556-8557	.	_

51-1	8558-8564	Second	_
51-2	8565-8566	,	_
51-3	8567-8569	we	_
51-4	8570-8574	used	_
51-5	8575-8578	the	_
51-6	8579-8583	full	_
51-7	8584-8587	DMN	_
51-8	8588-8593	atlas	_
51-9	8594-8595	(	_
51-10	8596-8598	12	_
51-11	8599-8603	ROIs	_
51-12	8604-8605	)	_
51-13	8606-8611	where	_
51-14	8612-8615	the	_
51-15	8616-8621	DMPFC	_
51-16	8622-8623	,	_
51-17	8624-8627	PMC	_
51-18	8628-8629	,	_
51-19	8630-8633	and	_
51-20	8634-8637	the	_
51-21	8638-8642	TPJs	_
51-22	8643-8646	are	_
51-23	8647-8658	represented	_
51-24	8659-8661	as	_
51-25	8662-8666	more	_
51-26	8667-8679	fine-grained	_
51-27	8680-8688	subnodes	_
51-28	8689-8690	(	_
51-29	8691-8694	Fig	_
51-30	8695-8696	.	_

52-1	8697-8700	1.B	_
52-2	8701-8702	.	_
52-3	8703-8704	)	_
52-4	8705-8706	.	_

53-1	8707-8710	The	_
53-2	8711-8716	DMPFC	_
53-3	8717-8720	was	_
53-4	8721-8731	segregated	_
53-5	8732-8736	into	_
53-6	8737-8738	a	_
53-7	8739-8743	left	_
53-8	8744-8747	and	_
53-9	8748-8753	right	_
53-10	8754-8760	caudal	_
53-11	8761-8768	subnode	_
53-12	8769-8772	and	_
53-13	8773-8774	a	_
53-14	8775-8789	rostro-ventral	_
53-15	8790-8793	and	_
53-16	8794-8807	rostro-dorsal	_
53-17	8808-8812	part	_
53-18	8813-8814	(	_
53-19	8815-8819	left	_
53-20	8820-8823	and	_
53-21	8824-8829	right	_
53-22	8830-8836	cDMPFC	_
53-23	8837-8838	,	_
53-24	8839-8846	rvDMPFC	_
53-25	8847-8850	and	_
53-26	8851-8858	rdDMPFC	_
53-27	8859-8860	)	_
53-28	8861-8862	.	_

54-1	8863-8867	Note	_
54-2	8868-8872	that	_
54-3	8873-8878	among	_
54-4	8879-8882	the	_
54-5	8883-8890	midline	_
54-6	8891-8901	structures	_
54-7	8902-8904	of	_
54-8	8905-8908	the	_
54-9	8909-8912	DMN	_
54-10	8913-8914	,	_
54-11	8915-8919	only	_
54-12	8920-8923	the	_
54-13	8924-8929	DMPFC	_
54-14	8930-8937	yielded	_
54-15	8938-8939	a	_
54-16	8940-8948	division	_
54-17	8949-8954	along	_
54-18	8955-8958	the	_
54-19	8959-8964	right	_
54-20	8965-8971	versus	_
54-21	8972-8976	left	_
54-22	8977-8987	hemisphere	_
54-23	8988-8990	in	_
54-24	8991-8994	the	_
54-25	8995-8998	DMN	_
54-26	8999-9006	subnode	_
54-27	9007-9012	atlas	_
54-28	9013-9014	.	_

55-1	9015-9018	The	_
55-2	9019-9023	left	_
55-3	9024-9027	and	_
55-4	9028-9033	right	_
55-5	9034-9038	TPJs	_
55-6	9039-9043	were	_
55-7	9044-9055	partitioned	_
55-8	9056-9060	into	_
55-9	9061-9063	an	_
55-10	9064-9072	anterior	_
55-11	9073-9076	and	_
55-12	9077-9086	posterior	_
55-13	9087-9094	subnode	_
55-14	9095-9096	(	_
55-15	9097-9101	left	_
55-16	9102-9105	and	_
55-17	9106-9111	right	_
55-18	9112-9116	aTPJ	_
55-19	9117-9120	and	_
55-20	9121-9125	pTPJ	_
55-21	9126-9127	)	_
55-22	9128-9129	.	_

56-1	9130-9133	The	_
56-2	9134-9137	PMC	_
56-3	9138-9141	was	_
56-4	9142-9153	parcellated	_
56-5	9154-9158	into	_
56-6	9159-9160	4	_
56-7	9161-9169	subnodes	_
56-8	9170-9171	,	_
56-9	9172-9181	including	_
56-10	9182-9185	the	_
56-11	9186-9195	precuneus	_
56-12	9196-9197	(	_
56-13	9198-9202	PREC	_
56-14	9203-9204	)	_
56-15	9205-9206	,	_
56-16	9207-9210	the	_
56-17	9211-9218	ventral	_
56-18	9219-9222	and	_
56-19	9223-9229	dorsal	_
56-20	9230-9239	posterior	_
56-21	9240-9249	cingulate	_
56-22	9250-9256	cortex	_
56-23	9257-9258	(	_
56-24	9259-9263	vPCC	_
56-25	9264-9267	and	_
56-26	9268-9272	dPCC	_
56-27	9273-9274	)	_
56-28	9275-9276	,	_
56-29	9277-9280	and	_
56-30	9281-9284	the	_
56-31	9285-9298	retrosplenial	_
56-32	9299-9305	cortex	_
56-33	9306-9307	(	_
56-34	9308-9311	RSC	_
56-35	9312-9313	)	_
56-36	9314-9315	.	_

57-1	9316-9319	The	_
57-2	9320-9333	corresponding	_
57-3	9334-9345	covariation	_
57-4	9346-9354	analyses	_
57-5	9355-9363	examined	_
57-6	9364-9367	the	_
57-7	9368-9378	hypothesis	_
57-8	9379-9383	that	_
57-9	9384-9387	the	_
57-10	9388-9391	DMN	_
57-11	9392-9395	can	_
57-12	9396-9398	be	_
57-13	9399-9404	shown	_
57-14	9405-9407	to	_
57-15	9408-9414	reveal	_
57-16	9415-9421	richer	_
57-17	9422-9431	structure	_
57-18	9432-9434	in	_
57-19	9435-9440	brain	_
57-20	9441-9448	signals	_
57-21	9449-9453	when	_
57-22	9454-9462	measured	_
57-23	9463-9465	by	_
57-24	9466-9478	conventional	_
57-25	9479-9482	MRI	_
57-26	9483-9491	scanners	_
57-27	9492-9494	at	_
57-28	9495-9498	the	_
57-29	9499-9504	level	_
57-30	9505-9507	of	_
57-31	9508-9515	network	_
57-32	9516-9524	subnodes	_
57-33	9525-9526	.	_

58-1	9527-9532	Third	_
58-2	9533-9534	,	_
58-3	9535-9538	the	_
58-4	9539-9542	DMN	_
58-5	9543-9550	subnode	_
58-6	9551-9556	atlas	_
58-7	9557-9558	(	_
58-8	9559-9561	12	_
58-9	9562-9566	ROIs	_
58-10	9567-9568	)	_
58-11	9569-9572	was	_
58-12	9573-9585	supplemented	_
58-13	9586-9588	by	_
58-14	9589-9594	nodes	_
58-15	9595-9599	from	_
58-16	9600-9603	two	_
58-17	9604-9615	multi-modal	_
58-18	9616-9624	networks	_
58-19	9625-9626	(	_
58-20	9627-9630	Fig	_
58-21	9631-9632	.	_

59-1	9633-9636	1.C	_
59-2	9637-9638	)	_
59-3	9639-9640	:	_
59-4	9641-9642	(	_
59-5	9643-9644	i	_
59-6	9645-9646	)	_
59-7	9647-9650	the	_
59-8	9651-9659	saliency	_
59-9	9660-9667	network	_
59-10	9668-9669	,	_
59-11	9670-9679	including	_
59-12	9680-9683	the	_
59-13	9684-9696	midcingulate	_
59-14	9697-9703	cortex	_
59-15	9704-9705	(	_
59-16	9706-9709	MCC	_
59-17	9710-9711	)	_
59-18	9712-9713	,	_
59-19	9714-9717	the	_
59-20	9718-9727	bilateral	_
59-21	9728-9736	anterior	_
59-22	9737-9743	insula	_
59-23	9744-9745	(	_
59-24	9746-9748	AI	_
59-25	9749-9750	)	_
59-26	9751-9754	and	_
59-27	9755-9758	the	_
59-28	9759-9767	amygdala	_
59-29	9768-9769	(	_
59-30	9770-9772	AM	_
59-31	9773-9774	)	_
59-32	9775-9776	,	_
59-33	9777-9780	and	_
59-34	9781-9782	(	_
59-35	9783-9785	ii	_
59-36	9786-9787	)	_
59-37	9788-9791	the	_
59-38	9792-9798	dorsal	_
59-39	9799-9808	attention	_
59-40	9809-9816	network	_
59-41	9817-9818	,	_
59-42	9819-9828	including	_
59-43	9829-9832	the	_
59-44	9833-9845	dorsolateral	_
59-45	9846-9856	prefrontal	_
59-46	9857-9863	cortex	_
59-47	9864-9865	(	_
59-48	9866-9871	DLPFC	_
59-49	9872-9873	)	_
59-50	9874-9877	and	_
59-51	9878-9881	the	_
59-52	9882-9895	intraparietal	_
59-53	9896-9902	sulcus	_
59-54	9903-9904	(	_
59-55	9905-9908	IPS	_
59-56	9909-9910	)	_
59-57	9911-9922	bilaterally	_
59-58	9923-9924	(	_
59-59	9925-9926	9	_
59-60	9927-9937	additional	_
59-61	9938-9942	ROIs	_
59-62	9943-9950	outside	_
59-63	9951-9953	of	_
59-64	9954-9957	the	_
59-65	9958-9961	DMN	_
59-66	9962-9963	)	_
59-67	9964-9965	.	_

60-1	9966-9977	Covariation	_
60-2	9978-9986	analyses	_
60-3	9987-9995	examined	_
60-4	9996-9999	the	_
60-5	10000-10010	hypothesis	_
60-6	10011-10015	that	_
60-7	10016-10019	the	_
60-8	10020-10023	DMN	_
60-9	10024-10032	subnodes	_
60-10	10033-10037	also	_
60-11	10038-10045	display	_
60-12	10046-10060	characteristic	_
60-13	10061-10073	interactions	_
60-14	10074-10078	with	_
60-15	10079-10082	the	_
60-16	10083-10088	nodes	_
60-17	10089-10091	of	_
60-18	10092-10097	other	_
60-19	10098-10107	canonical	_
60-20	10108-10113	brain	_
60-21	10114-10122	networks	_
60-22	10123-10124	.	_

61-1	10125-10131	Indeed	_
61-2	10132-10133	,	_
61-3	10134-10137	the	_
61-4	10138-10141	DAN	_
61-5	10142-10145	and	_
61-6	10146-10149	the	_
61-7	10150-10152	SN	http://maven.renci.org/NeuroBridge/neurobridge#Thing
61-8	10153-10157	have	_
61-9	10158-10162	been	_
61-10	10163-10173	implicated	_
61-11	10174-10176	in	_
61-12	10177-10188	attentional	_
61-13	10189-10198	switching	_
61-14	10199-10202	and	_
61-15	10203-10215	reallocation	_
61-16	10216-10218	of	_
61-17	10219-10224	focus	_
61-18	10225-10226	,	_
61-19	10227-10236	processes	_
61-20	10237-10241	that	_
61-21	10242-10245	are	_
61-22	10246-10254	markedly	_
61-23	10255-10264	disrupted	_
61-24	10265-10267	in	_
61-25	10268-10281	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
61-26	10282-10283	.	_

62-1	10284-10289	Based	_
62-2	10290-10292	on	_
62-3	10293-10301	coherent	_
62-4	10302-10314	connectivity	_
62-5	10315-10323	profiles	_
62-6	10324-10325	,	_
62-7	10326-10329	the	_
62-8	10330-10335	DMPFC	_
62-9	10336-10339	was	_
62-10	10340-10350	decomposed	_
62-11	10351-10355	into	_
62-12	10356-10359	two	_
62-13	10360-10366	caudal	_
62-14	10367-10370	and	_
62-15	10371-10374	two	_
62-16	10375-10382	rostral	_
62-17	10383-10391	subnodes	_
62-18	10392-10393	.	_

63-1	10394-10397	The	_
63-2	10398-10401	PMC	_
63-3	10402-10405	was	_
63-4	10406-10417	partitioned	_
63-5	10418-10422	into	_
63-6	10423-10424	a	_
63-7	10425-10432	ventral	_
63-8	10433-10436	and	_
63-9	10437-10443	dorsal	_
63-10	10444-10451	subnode	_
63-11	10452-10454	in	_
63-12	10455-10458	the	_
63-13	10459-10468	posterior	_
63-14	10469-10478	cingulate	_
63-15	10479-10485	cortex	_
63-16	10486-10489	and	_
63-17	10490-10493	one	_
63-18	10494-10496	in	_
63-19	10497-10500	the	_
63-20	10501-10514	retrosplenial	_
63-21	10515-10521	cortex	_
63-22	10522-10525	and	_
63-23	10526-10529	one	_
63-24	10530-10532	in	_
63-25	10533-10536	the	_
63-26	10537-10546	precuneus	_
63-27	10547-10548	.	_

64-1	10549-10556	Finally	_
64-2	10557-10558	,	_
64-3	10559-10562	the	_
64-4	10563-10567	left	_
64-5	10568-10571	and	_
64-6	10572-10577	right	_
64-7	10578-10582	TPJs	_
64-8	10583-10585	of	_
64-9	10586-10589	the	_
64-10	10590-10593	DMN	_
64-11	10594-10598	were	_
64-12	10599-10609	decomposed	_
64-13	10610-10614	into	_
64-14	10615-10617	an	_
64-15	10618-10626	anterior	_
64-16	10627-10630	and	_
64-17	10631-10632	a	_
64-18	10633-10642	posterior	_
64-19	10643-10650	subnode	_
64-20	10651-10652	.	_

65-1	10653-10661	Adopting	_
65-2	10662-10666	such	_
65-3	10667-10668	a	_
65-4	10669-10681	fine-grained	_
65-5	10682-10693	perspective	_
65-6	10694-10696	on	_
65-7	10697-10700	DMN	_
65-8	10701-10713	organization	_
65-9	10714-10717	may	_
65-10	10718-10725	provide	_
65-11	10726-10729	new	_
65-12	10730-10738	insights	_
65-13	10739-10743	into	_
65-14	10744-10747	the	_
65-15	10748-10763	pathophysiology	_
65-16	10764-10766	of	_
65-17	10767-10780	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
65-18	10781-10782	.	_

66-1	10783-10788	These	_
66-2	10789-10793	node	_
66-3	10794-10797	and	_
66-4	10798-10805	subnode	_
66-5	10806-10817	definitions	_
66-6	10818-10820	of	_
66-7	10821-10824	the	_
66-8	10825-10828	DMN	_
66-9	10829-10833	were	_
66-10	10834-10838	used	_
66-11	10839-10841	as	_
66-12	10842-10843	3	_
66-13	10844-10853	different	_
66-14	10854-10857	ROI	_
66-15	10858-10862	sets	_
66-16	10863-10864	(	_
66-17	10865-10867	cf	_
66-18	10868-10869	.	_

67-1	10870-10883	Supplementary	_
67-2	10884-10889	Table	_
67-3	10890-10891	3	_
67-4	10892-10893	)	_
67-5	10894-10895	:	_
67-6	10896-10898	In	_
67-7	10899-10902	sum	_
67-8	10903-10904	,	_
67-9	10905-10908	the	_
67-10	10909-10920	covariation	_
67-11	10921-10929	analyses	_
67-12	10930-10932	of	_
67-13	10933-10943	functional	_
67-14	10944-10952	coupling	_
67-15	10953-10956	and	_
67-16	10957-10967	volumetric	_
67-17	10968-10976	coupling	_
67-18	10977-10986	performed	_
67-19	10987-10989	in	_
67-20	10990-10993	the	_
67-21	10994-11001	present	_
67-22	11002-11007	study	_
67-23	11008-11012	were	_
67-24	11013-11018	based	_
67-25	11019-11021	on	_
67-26	11022-11023	3	_
67-27	11024-11033	different	_
67-28	11034-11038	sets	_
67-29	11039-11041	of	_
67-30	11042-11052	previously	_
67-31	11053-11064	established	_
67-32	11065-11072	regions	_
67-33	11073-11075	of	_
67-34	11076-11084	interest	_
67-35	11085-11086	.	_

68-1	11087-11099	Collectively	_
68-2	11100-11101	,	_
68-3	11102-11105	the	_
68-4	11106-11114	analyses	_
68-5	11115-11118	are	_
68-6	11119-11123	used	_
68-7	11124-11126	to	_
68-8	11127-11132	probe	_
68-9	11133-11136	the	_
68-10	11137-11140	DMN	_
68-11	11141-11143	at	_
68-12	11144-11153	different	_
68-13	11154-11161	spatial	_
68-14	11162-11173	resolutions	_
68-15	11174-11177	and	_
68-16	11178-11180	to	_
68-17	11181-11195	systematically	_
68-18	11196-11204	evaluate	_
68-19	11205-11210	their	_
68-20	11211-11220	relations	_
68-21	11221-11223	to	_
68-22	11224-11229	other	_
68-23	11230-11235	major	_
68-24	11236-11241	brain	_
68-25	11242-11250	networks	_
68-26	11251-11252	.	_

69-1	11253-11256	All	_
69-2	11257-11259	of	_
69-3	11260-11263	the	_
69-4	11264-11271	regions	_
69-5	11272-11274	of	_
69-6	11275-11283	interest	_
69-7	11284-11288	used	_
69-8	11289-11291	in	_
69-9	11292-11296	this	_
69-10	11297-11302	study	_
69-11	11303-11306	are	_
69-12	11307-11316	available	_
69-13	11317-11323	online	_
69-14	11324-11327	for	_
69-15	11328-11340	transparency	_
69-16	11341-11344	and	_
69-17	11345-11350	reuse	_
69-18	11351-11354	via	_
69-19	11355-11356	a	_
69-20	11357-11367	NeuroVault	_
69-21	11368-11377	permanent	_
69-22	11378-11382	link	_
69-23	11383-11384	(	_
69-24	11385-11389	http	_
69-25	11390-11391	:	_
69-26	11392-11426	//neurovault.org/collections/2216/	_
69-27	11427-11428	)	_
69-28	11429-11430	.	_

70-1	11431-11437	Signal	_
70-2	11438-11448	extraction	_
70-3	11449-11454	Using	_
70-4	11455-11458	the	_
70-5	11459-11464	three	_
70-6	11465-11469	sets	_
70-7	11470-11472	of	_
70-8	11473-11477	ROIs	_
70-9	11478-11487	described	_
70-10	11488-11493	above	_
70-11	11494-11495	,	_
70-12	11496-11508	quantitative	_
70-13	11509-11517	measures	_
70-14	11518-11520	of	_
70-15	11521-11531	functional	_
70-16	11532-11540	activity	_
70-17	11541-11544	and	_
70-18	11545-11556	grey-matter	_
70-19	11557-11563	volume	_
70-20	11564-11568	were	_
70-21	11569-11578	extracted	_
70-22	11579-11585	within	_
70-23	11586-11589	the	_
70-24	11590-11593	DMN	_
70-25	11594-11595	,	_
70-26	11596-11599	DAN	_
70-27	11600-11601	,	_
70-28	11602-11605	and	_
70-29	11606-11608	SN	_
70-30	11609-11613	ROIs	_
70-31	11614-11616	in	_
70-32	11617-11622	every	_
70-33	11623-11634	participant	_
70-34	11635-11636	.	_

71-1	11637-11641	Note	_
71-2	11642-11646	that	_
71-3	11647-11650	all	_
71-4	11651-11659	analyses	_
71-5	11660-11664	were	_
71-6	11665-11676	constrained	_
71-7	11677-11679	to	_
71-8	11680-11685	these	_
71-9	11686-11693	regions	_
71-10	11694-11696	of	_
71-11	11697-11705	interest	_
71-12	11706-11707	.	_

72-1	11708-11711	For	_
72-2	11712-11722	extracting	_
72-3	11723-11731	relevant	_
72-4	11732-11738	signal	_
72-5	11739-11743	from	_
72-6	11744-11747	the	_
72-7	11748-11758	functional	_
72-8	11759-11761	or	_
72-9	11762-11772	structural	_
72-10	11773-11778	brain	_
72-11	11779-11783	scan	_
72-12	11784-11785	,	_
72-13	11786-11789	the	_
72-14	11790-11794	ROIs	_
72-15	11795-11801	served	_
72-16	11802-11804	as	_
72-17	11805-11816	topographic	_
72-18	11817-11822	masks	_
72-19	11823-11827	used	_
72-20	11828-11830	to	_
72-21	11831-11838	average	_
72-22	11839-11842	the	_
72-23	11843-11846	MRI	_
72-24	11847-11853	signal	_
72-25	11854-11860	across	_
72-26	11861-11864	the	_
72-27	11865-11871	voxels	_
72-28	11872-11881	belonging	_
72-29	11882-11884	to	_
72-30	11885-11886	a	_
72-31	11887-11892	given	_
72-32	11893-11896	ROI	_
72-33	11897-11898	.	_

73-1	11899-11901	In	_
73-2	11902-11906	RSFC	_
73-3	11907-11908	,	_
73-4	11909-11913	each	_
73-5	11914-11920	target	_
73-6	11921-11927	region	_
73-7	11928-11931	was	_
73-8	11932-11943	represented	_
73-9	11944-11946	by	_
73-10	11947-11950	the	_
73-11	11951-11958	average	_
73-12	11959-11963	BOLD	_
73-13	11964-11970	signal	_
73-14	11971-11977	across	_
73-15	11978-11981	all	_
73-16	11982-11988	voxels	_
73-17	11989-11991	of	_
73-18	11992-11996	that	_
73-19	11997-12000	ROI	_
73-20	12001-12002	.	_

74-1	12003-12007	This	_
74-2	12008-12027	feature-engineering	_
74-3	12028-12036	strategy	_
74-4	12037-12044	yielded	_
74-5	12045-12047	as	_
74-6	12048-12052	many	_
74-7	12053-12063	functional	_
74-8	12064-12069	brain	_
74-9	12070-12079	variables	_
74-10	12080-12082	as	_
74-11	12083-12089	target	_
74-12	12090-12097	regions	_
74-13	12098-12100	in	_
74-14	12101-12104	the	_
74-15	12105-12108	ROI	_
74-16	12109-12112	set	_
74-17	12113-12116	for	_
74-18	12117-12120	the	_
74-19	12121-12133	participants	_
74-20	12134-12135	.	_

75-1	12136-12138	In	_
75-2	12139-12142	VBM	_
75-3	12143-12144	,	_
75-4	12145-12149	each	_
75-5	12150-12156	target	_
75-6	12157-12163	region	_
75-7	12164-12166	in	_
75-8	12167-12170	the	_
75-9	12171-12181	respective	_
75-10	12182-12185	set	_
75-11	12186-12188	of	_
75-12	12189-12193	ROIs	_
75-13	12194-12197	was	_
75-14	12198-12209	represented	_
75-15	12210-12212	by	_
75-16	12213-12216	the	_
75-17	12217-12224	average	_
75-18	12225-12229	gray	_
75-19	12230-12236	matter	_
75-20	12237-12243	volume	_
75-21	12244-12250	across	_
75-22	12251-12254	all	_
75-23	12255-12258	ROI	_
75-24	12259-12265	voxels	_
75-25	12266-12267	.	_

76-1	12268-12279	Analogously	_
76-2	12280-12281	,	_
76-3	12282-12286	this	_
76-4	12287-12290	way	_
76-5	12291-12293	of	_
76-6	12294-12305	engineering	_
76-7	12306-12319	morphological	_
76-8	12320-12325	brain	_
76-9	12326-12334	features	_
76-10	12335-12342	yielded	_
76-11	12343-12345	as	_
76-12	12346-12350	many	_
76-13	12351-12361	volumetric	_
76-14	12362-12367	brain	_
76-15	12368-12377	variables	_
76-16	12378-12381	per	_
76-17	12382-12393	participant	_
76-18	12394-12396	as	_
76-19	12397-12400	the	_
76-20	12401-12406	total	_
76-21	12407-12413	number	_
76-22	12414-12416	of	_
76-23	12417-12421	ROIs	_
76-24	12422-12424	in	_
76-25	12425-12428	the	_
76-26	12429-12436	current	_
76-27	12437-12440	set	_
76-28	12441-12442	.	_

77-1	12443-12446	All	_
77-2	12447-12455	ROI-wise	_
77-3	12456-12466	functional	_
77-4	12467-12469	or	_
77-5	12470-12480	structural	_
77-6	12481-12485	time	_
77-7	12486-12492	series	_
77-8	12493-12497	were	_
77-9	12498-12509	transformed	_
77-10	12510-12514	into	_
77-11	12515-12523	z-scores	_
77-12	12524-12526	by	_
77-13	12527-12531	mean	_
77-14	12532-12541	centering	_
77-15	12542-12545	and	_
77-16	12546-12559	unit-variance	_
77-17	12560-12567	scaling	_
77-18	12568-12569	.	_

78-1	12570-12572	As	_
78-2	12573-12577	part	_
78-3	12578-12580	of	_
78-4	12581-12584	the	_
78-5	12585-12601	confound-removal	_
78-6	12602-12611	procedure	_
78-7	12612-12613	,	_
78-8	12614-12622	variance	_
78-9	12623-12627	that	_
78-10	12628-12633	could	_
78-11	12634-12636	be	_
78-12	12637-12646	explained	_
78-13	12647-12649	by	_
78-14	12650-12653	the	_
78-15	12654-12661	factors	_
78-16	12662-12663	â€œ	_
78-17	12664-12668	site	_
78-18	12669-12670	,	_
78-19	12671-12672	â€	_
78-20	12673-12674	â€œ	_
78-21	12675-12678	age	_
78-22	12679-12680	,	_
78-23	12681-12682	â€	_
78-24	12683-12686	and	_
78-25	12687-12688	â€œ	_
78-26	12689-12695	gender	_
78-27	12696-12697	â€	_
78-28	12698-12700	as	_
78-29	12701-12705	well	_
78-30	12706-12708	as	_
78-31	12709-12714	their	_
78-32	12715-12722	two-way	_
78-33	12723-12735	interactions	_
78-34	12736-12739	was	_
78-35	12740-12749	regressed	_
78-36	12750-12753	out	_
78-37	12754-12758	from	_
78-38	12759-12762	the	_
78-39	12763-12776	corresponding	_
78-40	12777-12785	features	_
78-41	12786-12787	.	_

79-1	12788-12797	Measuring	_
79-2	12798-12805	network	_
79-3	12806-12817	covariation	_
79-4	12818-12819	:	_
79-5	12820-12826	Sparse	_
79-6	12827-12834	inverse	_
79-7	12835-12845	covariance	_
79-8	12846-12856	estimation	_
79-9	12857-12867	Covariance	_
79-10	12868-12871	has	_
79-11	12872-12876	been	_
79-12	12877-12883	argued	_
79-13	12884-12886	to	_
79-14	12887-12889	be	_
79-15	12890-12891	a	_
79-16	12892-12895	key	_
79-17	12896-12902	notion	_
79-18	12903-12907	when	_
79-19	12908-12918	estimating	_
79-20	12919-12922	the	_
79-21	12923-12934	statistical	_
79-22	12935-12947	dependencies	_
79-23	12948-12962	characteristic	_
79-24	12963-12965	of	_
79-25	12966-12977	small-scale	_
79-26	12978-12984	neural	_
79-27	12985-12993	circuits	_
79-28	12994-12997	and	_
79-29	12998-13009	large-scale	_
79-30	13010-13015	brain	_
79-31	13016-13024	networks	_
79-32	13025-13026	.	_

80-1	13027-13029	In	_
80-2	13030-13033	the	_
80-3	13034-13041	present	_
80-4	13042-13047	study	_
80-5	13048-13049	,	_
80-6	13050-13052	we	_
80-7	13053-13057	have	_
80-8	13058-13067	performed	_
80-9	13068-13074	formal	_
80-10	13075-13084	inference	_
80-11	13085-13087	of	_
80-12	13088-13095	salient	_
80-13	13096-13106	covariance	_
80-14	13107-13116	relations	_
80-15	13117-13119	in	_
80-16	13120-13130	functional	_
80-17	13131-13132	(	_
80-18	13133-13137	i.e.	_
80-19	13138-13139	,	_
80-20	13140-13144	RSFC	_
80-21	13145-13146	)	_
80-22	13147-13150	and	_
80-23	13151-13161	volumetric	_
80-24	13162-13163	(	_
80-25	13164-13168	i.e.	_
80-26	13169-13170	,	_
80-27	13171-13174	VBM	_
80-28	13175-13176	)	_
80-29	13177-13185	networks	_
80-30	13186-13187	(	_
80-31	13188-13190	or	_
80-32	13191-13197	graphs	_
80-33	13198-13199	,	_
80-34	13200-13214	mathematically	_
80-35	13215-13223	speaking	_
80-36	13224-13225	)	_
80-37	13226-13231	using	_
80-38	13232-13238	sparse	_
80-39	13239-13246	inverse	_
80-40	13247-13257	covariance	_
80-41	13258-13268	estimation	_
80-42	13269-13270	.	_

81-1	13271-13274	The	_
81-2	13275-13284	automatic	_
81-3	13285-13299	identification	_
81-4	13300-13302	of	_
81-5	13303-13312	networked	_
81-6	13313-13325	organization	_
81-7	13326-13328	in	_
81-8	13329-13338	graphical	_
81-9	13339-13345	models	_
81-10	13346-13348	is	_
81-11	13349-13351	an	_
81-12	13352-13361	important	_
81-13	13362-13366	step	_
81-14	13367-13377	supporting	_
81-15	13378-13381	the	_
81-16	13382-13392	transition	_
81-17	13393-13397	from	_
81-18	13398-13409	descriptive	_
81-19	13410-13420	statistics	_
81-20	13421-13425	such	_
81-21	13426-13428	as	_
81-22	13429-13436	Pearson	_
81-23	13437-13438	â€™	_
81-24	13439-13440	s	_
81-25	13441-13452	correlation	_
81-26	13453-13464	coefficient	_
81-27	13465-13467	to	_
81-28	13468-13478	generative	_
81-29	13479-13485	models	_
81-30	13486-13490	that	_
81-31	13491-13498	capture	_
81-32	13499-13511	higher-order	_
81-33	13512-13524	interactions	_
81-34	13525-13526	.	_

82-1	13527-13531	Here	_
82-2	13532-13533	,	_
82-3	13534-13537	the	_
82-4	13538-13546	employed	_
82-5	13547-13558	statistical	_
82-6	13559-13568	estimator	_
82-7	13569-13579	represents	_
82-8	13580-13582	an	_
82-9	13583-13593	adaptation	_
82-10	13594-13596	of	_
82-11	13597-13607	Lasso-like	_
82-12	13608-13618	regression	_
82-13	13619-13625	models	_
82-14	13626-13628	to	_
82-15	13629-13637	Gaussian	_
82-16	13638-13647	graphical	_
82-17	13648-13654	models	_
82-18	13655-13656	,	_
82-19	13657-13659	an	_
82-20	13660-13668	approach	_
82-21	13669-13673	that	_
82-22	13674-13677	has	_
82-23	13678-13686	recently	_
82-24	13687-13691	been	_
82-25	13692-13699	adapted	_
82-26	13700-13703	for	_
82-27	13704-13715	application	_
82-28	13716-13720	into	_
82-29	13721-13733	neuroimaging	_
82-30	13734-13738	data	_
82-31	13739-13740	.	_

83-1	13741-13744	The	_
83-2	13745-13755	predictive	_
83-3	13756-13764	validity	_
83-4	13765-13767	of	_
83-5	13768-13771	the	_
83-6	13772-13779	derived	_
83-7	13780-13793	probabilistic	_
83-8	13794-13806	descriptions	_
83-9	13807-13809	of	_
83-10	13810-13813	the	_
83-11	13814-13822	coupling	_
83-12	13823-13833	properties	_
83-13	13834-13836	in	_
83-14	13837-13840	DMN	_
83-15	13841-13849	function	_
83-16	13850-13853	and	_
83-17	13854-13860	volume	_
83-18	13861-13864	was	_
83-19	13865-13876	ascertained	_
83-20	13877-13879	by	_
83-21	13880-13896	cross-validation	_
83-22	13897-13898	(	_
83-23	13899-13900	3	_
83-24	13901-13906	folds	_
83-25	13907-13908	)	_
83-26	13909-13910	.	_

84-1	13911-13916	These	_
84-2	13917-13924	schemes	_
84-3	13925-13932	ensured	_
84-4	13933-13940	pattern	_
84-5	13941-13955	generalization	_
84-6	13956-13958	by	_
84-7	13959-13968	measuring	_
84-8	13969-13972	the	_
84-9	13973-13981	goodness	_
84-10	13982-13984	of	_
84-11	13985-13988	fit	_
84-12	13989-13991	in	_
84-13	13992-13998	unseen	_
84-14	13999-14003	data	_
84-15	14004-14006	as	_
84-16	14007-14008	a	_
84-17	14009-14014	proxy	_
84-18	14015-14018	for	_
84-19	14019-14032	extrapolation	_
84-20	14033-14035	to	_
84-21	14036-14039	the	_
84-22	14040-14047	general	_
84-23	14048-14058	population	_
84-24	14059-14060	.	_

85-1	14061-14065	This	_
85-2	14066-14074	approach	_
85-3	14075-14086	facilitated	_
85-4	14087-14092	model	_
85-5	14093-14102	selection	_
85-6	14103-14106	for	_
85-7	14107-14122	hyper-parameter	_
85-8	14123-14129	choice	_
85-9	14130-14134	with	_
85-10	14135-14137	an	_
85-11	14138-14149	iteratively	_
85-12	14150-14157	refined	_
85-13	14158-14162	grid	_
85-14	14163-14168	based	_
85-15	14169-14171	on	_
85-16	14172-14175	the	_
85-17	14176-14190	log-likelihood	_
85-18	14191-14196	score	_
85-19	14197-14199	on	_
85-20	14200-14208	left-out	_
85-21	14209-14214	brain	_
85-22	14215-14219	data	_
85-23	14220-14221	(	_
85-24	14222-14229	default	_
85-25	14230-14240	parameters	_
85-26	14241-14245	were	_
85-27	14246-14252	chosen	_
85-28	14253-14262	according	_
85-29	14263-14265	to	_
85-30	14266-14267	)	_
85-31	14268-14269	.	_

86-1	14270-14272	In	_
86-2	14273-14274	a	_
86-3	14275-14280	first	_
86-4	14281-14285	step	_
86-5	14286-14287	,	_
86-6	14288-14290	we	_
86-7	14291-14295	have	_
86-8	14296-14304	computed	_
86-9	14305-14308	the	_
86-10	14309-14318	empirical	_
86-11	14319-14329	covariance	_
86-12	14330-14336	matrix	_
86-13	14337-14338	(	_
86-14	14339-14342	Fig	_
86-15	14343-14344	.	_

87-1	14345-14347	2A	_
87-2	14348-14349	)	_
87-3	14350-14351	.	_

88-1	14352-14356	This	_
88-2	14357-14363	simple	_
88-3	14364-14376	second-order	_
88-4	14377-14386	statistic	_
88-5	14387-14395	reflects	_
88-6	14396-14399	how	_
88-7	14400-14408	strongly	_
88-8	14409-14412	the	_
88-9	14413-14418	times	_
88-10	14419-14425	series	_
88-11	14426-14428	of	_
88-12	14429-14432	ROI	_
88-13	14433-14438	pairs	_
88-14	14439-14445	covary	_
88-15	14446-14447	(	_
88-16	14448-14450	in	_
88-17	14451-14456	terms	_
88-18	14457-14459	of	_
88-19	14460-14470	functional	_
88-20	14471-14479	coupling	_
88-21	14480-14482	in	_
88-22	14483-14486	the	_
88-23	14487-14491	RSFC	_
88-24	14492-14500	analysis	_
88-25	14501-14503	or	_
88-26	14504-14514	volumetric	_
88-27	14515-14523	coupling	_
88-28	14524-14526	in	_
88-29	14527-14530	the	_
88-30	14531-14534	VBM	_
88-31	14535-14543	analysis	_
88-32	14544-14545	)	_
88-33	14546-14547	.	_

89-1	14548-14551	The	_
89-2	14552-14561	empirical	_
89-3	14562-14572	covariance	_
89-4	14573-14579	matrix	_
89-5	14580-14582	is	_
89-6	14583-14588	given	_
89-7	14589-14591	by	_
89-8	14592-14597	where	_
89-9	14598-14604	Ï‡âˆˆâ„nxp	_
89-10	14605-14612	denotes	_
89-11	14613-14616	the	_
89-12	14617-14622	input	_
89-13	14623-14630	dataset	_
89-14	14631-14635	with	_
89-15	14636-14637	p	_
89-16	14638-14647	variables	_
89-17	14648-14649	(	_
89-18	14650-14654	i.e.	_
89-19	14655-14656	,	_
89-20	14657-14667	functional	_
89-21	14668-14673	brain	_
89-22	14674-14681	signals	_
89-23	14682-14690	averaged	_
89-24	14691-14694	per	_
89-25	14695-14698	ROI	_
89-26	14699-14702	for	_
89-27	14703-14706	the	_
89-28	14707-14711	RSFC	_
89-29	14712-14720	analysis	_
89-30	14721-14724	and	_
89-31	14725-14735	structural	_
89-32	14736-14741	brain	_
89-33	14742-14749	signals	_
89-34	14750-14758	averaged	_
89-35	14759-14762	per	_
89-36	14763-14766	ROI	_
89-37	14767-14770	for	_
89-38	14771-14774	the	_
89-39	14775-14778	VBM	_
89-40	14779-14787	analysis	_
89-41	14788-14789	)	_
89-42	14790-14793	and	_
89-43	14794-14795	n	_
89-44	14796-14803	samples	_
89-45	14804-14805	(	_
89-46	14806-14810	i.e.	_
89-47	14811-14812	,	_
89-48	14813-14818	brain	_
89-49	14819-14824	scans	_
89-50	14825-14826	)	_
89-51	14827-14828	.	_

90-1	14829-14832	Ï‡TÏ‡	_
90-2	14833-14840	denotes	_
90-3	14841-14844	the	_
90-4	14845-14850	inner	_
90-5	14851-14858	product	_
90-6	14859-14860	,	_
90-7	14861-14864	the	_
90-8	14865-14879	multiplication	_
90-9	14880-14882	of	_
90-10	14883-14886	the	_
90-11	14887-14893	matrix	_
90-12	14894-14895	Ï‡	_
90-13	14896-14900	with	_
90-14	14901-14904	its	_
90-15	14905-14914	transpose	_
90-16	14915-14917	Ï‡T	_
90-17	14918-14919	.	_

91-1	14920-14923	The	_
91-2	14924-14930	signed	_
91-3	14931-14937	values	_
91-4	14938-14940	in	_
91-5	14941-14944	the	_
91-6	14945-14955	covariance	_
91-7	14956-14962	matrix	_
91-8	14963-14971	indicate	_
91-9	14972-14975	the	_
91-10	14976-14985	direction	_
91-11	14986-14988	of	_
91-12	14989-14992	the	_
91-13	14993-14999	linear	_
91-14	15000-15012	relationship	_
91-15	15013-15020	between	_
91-16	15021-15024	two	_
91-17	15025-15034	variables	_
91-18	15035-15036	.	_

92-1	15037-15041	This	_
92-2	15042-15045	way	_
92-3	15046-15048	of	_
92-4	15049-15058	capturing	_
92-5	15059-15062	the	_
92-6	15063-15074	covariation	_
92-7	15075-15077	in	_
92-8	15078-15084	signal	_
92-9	15085-15094	amplitude	_
92-10	15095-15102	between	_
92-11	15103-15106	any	_
92-12	15107-15110	two	_
92-13	15111-15115	ROIs	_
92-14	15116-15119	was	_
92-15	15120-15128	computed	_
92-16	15129-15136	without	_
92-17	15137-15150	statistically	_
92-18	15151-15164	acknowledging	_
92-19	15165-15168	the	_
92-20	15169-15177	possible	_
92-21	15178-15187	influence	_
92-22	15188-15192	from	_
92-23	15193-15196	the	_
92-24	15197-15202	other	_
92-25	15203-15207	ROIs	_
92-26	15208-15209	.	_

93-1	15210-15215	Every	_
93-2	15216-15226	individual	_
93-3	15227-15232	value	_
93-4	15233-15235	in	_
93-5	15236-15239	the	_
93-6	15240-15250	covariance	_
93-7	15251-15257	matrix	_
93-8	15258-15261	can	_
93-9	15262-15264	be	_
93-10	15265-15271	viewed	_
93-11	15272-15274	as	_
93-12	15275-15276	a	_
93-13	15277-15284	Pearson	_
93-14	15285-15286	â€™	_
93-15	15287-15288	s	_
93-16	15289-15295	linear	_
93-17	15296-15307	correlation	_
93-18	15308-15315	between	_
93-19	15316-15320	each	_
93-20	15321-15325	pair	_
93-21	15326-15328	of	_
93-22	15329-15333	ROIs	_
93-23	15334-15335	,	_
93-24	15336-15344	provided	_
93-25	15345-15349	that	_
93-26	15350-15353	the	_
93-27	15354-15358	time	_
93-28	15359-15365	series	_
93-29	15366-15367	X	_
93-30	15368-15372	were	_
93-31	15373-15386	mean-centered	_
93-32	15387-15390	and	_
93-33	15391-15404	unit-variance	_
93-34	15405-15411	scaled	_
93-35	15412-15413	.	_

94-1	15414-15422	Although	_
94-2	15423-15426	the	_
94-3	15427-15436	strengths	_
94-4	15437-15439	of	_
94-5	15440-15451	correlation	_
94-6	15452-15459	between	_
94-7	15460-15464	time	_
94-8	15465-15471	series	_
94-9	15472-15474	of	_
94-10	15475-15478	ROI	_
94-11	15479-15484	pairs	_
94-12	15485-15489	were	_
94-13	15490-15500	considered	_
94-14	15501-15503	in	_
94-15	15504-15513	isolation	_
94-16	15514-15515	,	_
94-17	15516-15521	these	_
94-18	15522-15533	covariation	_
94-19	15534-15542	strength	_
94-20	15543-15552	estimates	_
94-21	15553-15557	were	_
94-22	15558-15564	likely	_
94-23	15565-15567	to	_
94-24	15568-15570	be	_
94-25	15571-15581	confounded	_
94-26	15582-15586	with	_
94-27	15587-15591	each	_
94-28	15592-15597	other	_
94-29	15598-15599	.	_

95-1	15600-15603	For	_
95-2	15604-15612	instance	_
95-3	15613-15614	,	_
95-4	15615-15616	a	_
95-5	15617-15623	strong	_
95-6	15624-15633	influence	_
95-7	15634-15636	of	_
95-8	15637-15640	ROI	_
95-9	15641-15642	1	_
95-10	15643-15645	on	_
95-11	15646-15650	both	_
95-12	15651-15654	ROI	_
95-13	15655-15656	2	_
95-14	15657-15660	and	_
95-15	15661-15664	ROI	_
95-16	15665-15666	3	_
95-17	15667-15672	would	_
95-18	15673-15679	entail	_
95-19	15680-15684	high	_
95-20	15685-15694	estimates	_
95-21	15695-15697	of	_
95-22	15698-15709	covariation	_
95-23	15710-15717	between	_
95-24	15718-15721	ROI	_
95-25	15722-15723	2	_
95-26	15724-15727	and	_
95-27	15728-15731	ROI	_
95-28	15732-15733	3	_
95-29	15734-15735	.	_

96-1	15736-15740	This	_
96-2	15741-15749	confound	_
96-3	15750-15752	in	_
96-4	15753-15756	the	_
96-5	15757-15768	correlation	_
96-6	15769-15778	structure	_
96-7	15779-15786	between	_
96-8	15787-15790	any	_
96-9	15791-15794	two	_
96-10	15795-15800	given	_
96-11	15801-15807	target	_
96-12	15808-15815	regions	_
96-13	15816-15819	may	_
96-14	15820-15829	therefore	_
96-15	15830-15833	not	_
96-16	15834-15844	accurately	_
96-17	15845-15853	indicate	_
96-18	15854-15857	the	_
96-19	15858-15868	underlying	_
96-20	15869-15885	population-level	_
96-21	15886-15897	interaction	_
96-22	15898-15906	strength	_
96-23	15907-15908	.	_

97-1	15909-15911	In	_
97-2	15912-15913	a	_
97-3	15914-15920	second	_
97-4	15921-15925	step	_
97-5	15926-15936	addressing	_
97-6	15937-15941	this	_
97-7	15942-15950	confound	_
97-8	15951-15954	and	_
97-9	15955-15964	enhancing	_
97-10	15965-15980	neurobiological	_
97-11	15981-15997	interpretability	_
97-12	15998-15999	,	_
97-13	16000-16002	we	_
97-14	16003-16011	computed	_
97-15	16012-16015	the	_
97-16	16016-16023	partial	_
97-17	16024-16036	correlations	_
97-18	16037-16040	via	_
97-19	16041-16044	the	_
97-20	16045-16057	mathematical	_
97-21	16058-16065	inverse	_
97-22	16066-16068	of	_
97-23	16069-16072	the	_
97-24	16073-16083	covariance	_
97-25	16084-16090	matrix	_
97-26	16091-16092	,	_
97-27	16093-16096	the	_
97-28	16097-16106	so-called	_
97-29	16107-16116	precision	_
97-30	16117-16123	matrix	_
97-31	16124-16125	(	_
97-32	16126-16129	Fig	_
97-33	16130-16131	.	_

98-1	16132-16134	2B	_
98-2	16135-16136	)	_
98-3	16137-16138	.	_

99-1	16139-16142	The	_
99-2	16143-16155	optimization	_
99-3	16156-16165	objective	_
99-4	16166-16168	is	_
99-5	16169-16178	expressed	_
99-6	16179-16181	by	_
99-7	16182-16187	where	_
99-8	16188-16190	is	_
99-9	16191-16194	the	_
99-10	16195-16204	empirical	_
99-11	16205-16215	covariance	_
99-12	16216-16222	matrix	_
99-13	16223-16224	,	_
99-14	16225-16229	âˆ¥Â·âˆ¥1	_
99-15	16230-16237	denotes	_
99-16	16238-16241	the	_
99-17	16242-16256	regularization	_
99-18	16257-16267	constraint	_
99-19	16268-16270	of	_
99-20	16271-16278	putting	_
99-21	16279-16281	an	_
99-22	16282-16284	ð“1	_
99-23	16285-16289	norm	_
99-24	16290-16292	on	_
99-25	16293-16296	the	_
99-26	16297-16303	matrix	_
99-27	16304-16312	elements	_
99-28	16313-16318	lying	_
99-29	16319-16322	off	_
99-30	16323-16326	the	_
99-31	16327-16335	diagonal	_
99-32	16336-16338	of	_
99-33	16339-16342	the	_
99-34	16343-16352	precision	_
99-35	16353-16359	matrix	_
99-36	16360-16361	K	_
99-37	16362-16363	,	_
99-38	16364-16367	and	_
99-39	16368-16369	Î»	_
99-40	16370-16378	controls	_
99-41	16379-16382	the	_
99-42	16383-16389	amount	_
99-43	16390-16392	of	_
99-44	16393-16397	this	_
99-45	16398-16406	sparsity	_
99-46	16407-16417	constraint	_
99-47	16418-16419	.	_

100-1	16420-16422	In	_
100-2	16423-16431	contrast	_
100-3	16432-16434	to	_
100-4	16435-16443	ordinary	_
100-5	16444-16450	linear	_
100-6	16451-16462	correlation	_
100-7	16463-16469	matrix	_
100-8	16470-16472	or	_
100-9	16473-16475	to	_
100-10	16476-16479	the	_
100-11	16480-16489	empirical	_
100-12	16490-16500	covariance	_
100-13	16501-16507	matrix	_
100-14	16508-16517	described	_
100-15	16518-16523	above	_
100-16	16524-16525	,	_
100-17	16526-16530	this	_
100-18	16531-16537	matrix	_
100-19	16538-16547	estimates	_
100-20	16548-16551	the	_
100-21	16552-16563	covariation	_
100-22	16564-16571	between	_
100-23	16572-16577	every	_
100-24	16578-16581	two	_
100-25	16582-16586	ROIs	_
100-26	16587-16592	while	_
100-27	16593-16605	conditioning	_
100-28	16606-16608	on	_
100-29	16609-16612	the	_
100-30	16613-16622	potential	_
100-31	16623-16632	influence	_
100-32	16633-16635	of	_
100-33	16636-16639	the	_
100-34	16640-16649	remaining	_
100-35	16650-16657	regions	_
100-36	16658-16659	.	_

101-1	16660-16662	In	_
101-2	16663-16668	other	_
101-3	16669-16674	words	_
101-4	16675-16676	,	_
101-5	16677-16680	the	_
101-6	16681-16690	precision	_
101-7	16691-16697	matrix	_
101-8	16698-16705	obtains	_
101-9	16706-16709	the	_
101-10	16710-16716	direct	_
101-11	16717-16728	covariation	_
101-12	16729-16736	between	_
101-13	16737-16740	two	_
101-14	16741-16746	nodes	_
101-15	16747-16753	within	_
101-16	16754-16757	and	_
101-17	16758-16765	between	_
101-18	16766-16769	the	_
101-19	16770-16773	DMN	_
101-20	16774-16775	,	_
101-21	16776-16778	SN	_
101-22	16779-16780	,	_
101-23	16781-16784	and	_
101-24	16785-16788	DAN	_
101-25	16789-16791	by	_
101-26	16792-16802	accounting	_
101-27	16803-16806	for	_
101-28	16807-16814	partial	_
101-29	16815-16827	correlations	_
101-30	16828-16829	;	_
101-31	16830-16836	unlike	_
101-32	16837-16843	common	_
101-33	16844-16850	linear	_
101-34	16851-16862	correlation	_
101-35	16863-16873	approaches	_
101-36	16874-16875	,	_
101-37	16876-16878	it	_
101-38	16879-16883	does	_
101-39	16884-16887	not	_
101-40	16888-16897	privilege	_
101-41	16898-16910	polysynaptic	_
101-42	16911-16919	coupling	_
101-43	16920-16928	patterns	_
101-44	16929-16930	.	_

102-1	16931-16937	Coming	_
102-2	16938-16942	back	_
102-3	16943-16945	to	_
102-4	16946-16949	our	_
102-5	16950-16953	toy	_
102-6	16954-16961	example	_
102-7	16962-16963	,	_
102-8	16964-16966	we	_
102-9	16967-16972	would	_
102-10	16973-16977	thus	_
102-11	16978-16984	obtain	_
102-12	16985-16988	the	_
102-13	16989-17002	conditionally	_
102-14	17003-17014	independent	_
102-15	17015-17025	proportion	_
102-16	17026-17028	of	_
102-17	17029-17040	covariation	_
102-18	17041-17049	strength	_
102-19	17050-17057	between	_
102-20	17058-17061	ROI	_
102-21	17062-17063	2	_
102-22	17064-17067	and	_
102-23	17068-17071	ROI	_
102-24	17072-17073	3	_
102-25	17074-17078	that	_
102-26	17079-17081	is	_
102-27	17082-17085	not	_
102-28	17086-17095	explained	_
102-29	17096-17098	by	_
102-30	17099-17102	the	_
102-31	17103-17111	conjoint	_
102-32	17112-17121	influence	_
102-33	17122-17126	from	_
102-34	17127-17130	ROI	_
102-35	17131-17132	1	_
102-36	17133-17134	.	_

103-1	17135-17142	Despite	_
103-2	17143-17146	its	_
103-3	17147-17154	utility	_
103-4	17155-17156	,	_
103-5	17157-17161	this	_
103-6	17162-17173	statistical	_
103-7	17174-17182	approach	_
103-8	17183-17185	is	_
103-9	17186-17191	often	_
103-10	17192-17203	challenging	_
103-11	17204-17206	to	_
103-12	17207-17212	apply	_
103-13	17213-17215	in	_
103-14	17216-17221	small	_
103-15	17222-17229	samples	_
103-16	17230-17231	(	_
103-17	17232-17237	which	_
103-18	17238-17240	is	_
103-19	17241-17253	particularly	_
103-20	17254-17257	the	_
103-21	17258-17262	case	_
103-22	17263-17265	of	_
103-23	17266-17269	the	_
103-24	17270-17273	VBM	_
103-25	17274-17278	data	_
103-26	17279-17281	in	_
103-27	17282-17285	the	_
103-28	17286-17293	present	_
103-29	17294-17299	study	_
103-30	17300-17301	)	_
103-31	17302-17303	.	_

104-1	17304-17306	In	_
104-2	17307-17310	any	_
104-3	17311-17318	dataset	_
104-4	17319-17325	Ï‡âˆˆâ„nxp	_
104-5	17326-17327	,	_
104-6	17328-17340	considerable	_
104-7	17341-17351	estimation	_
104-8	17352-17358	errors	_
104-9	17359-17362	can	_
104-10	17363-17368	arise	_
104-11	17369-17373	when	_
104-12	17374-17377	the	_
104-13	17378-17384	number	_
104-14	17385-17387	of	_
104-15	17388-17395	unknown	_
104-16	17396-17401	model	_
104-17	17402-17412	parameters	_
104-18	17413-17420	exceeds	_
104-19	17421-17424	the	_
104-20	17425-17431	number	_
104-21	17432-17434	of	_
104-22	17435-17442	samples	_
104-23	17443-17445	by	_
104-24	17446-17447	.	_

105-1	17448-17450	To	_
105-2	17451-17459	overcome	_
105-3	17460-17469	erroneous	_
105-4	17470-17484	eigenstructure	_
105-5	17485-17486	,	_
105-6	17487-17498	statistical	_
105-7	17499-17511	conditioning	_
105-8	17512-17515	was	_
105-9	17516-17524	improved	_
105-10	17525-17527	by	_
105-11	17528-17536	imposing	_
105-12	17537-17545	sparsity	_
105-13	17546-17557	assumptions	_
105-14	17558-17560	by	_
105-15	17561-17566	means	_
105-16	17567-17569	of	_
105-17	17570-17572	ð“1	_
105-18	17573-17585	penalization	_
105-19	17586-17587	(	_
105-20	17588-17591	Fig	_
105-21	17592-17593	.	_

106-1	17594-17596	2C	_
106-2	17597-17598	)	_
106-3	17599-17601	of	_
106-4	17602-17605	the	_
106-5	17606-17613	inverse	_
106-6	17614-17624	covariance	_
106-7	17625-17635	estimation	_
106-8	17636-17637	.	_

107-1	17638-17640	In	_
107-2	17641-17644	the	_
107-3	17645-17649	case	_
107-4	17650-17652	of	_
107-5	17653-17665	multivariate	_
107-6	17666-17674	Gaussian	_
107-7	17675-17681	models	_
107-8	17682-17683	,	_
107-9	17684-17695	conditional	_
107-10	17696-17708	independence	_
107-11	17709-17716	between	_
107-12	17717-17721	ROIs	_
107-13	17722-17724	is	_
107-14	17725-17730	given	_
107-15	17731-17733	by	_
107-16	17734-17737	the	_
107-17	17738-17742	zero	_
107-18	17743-17750	entries	_
107-19	17751-17753	in	_
107-20	17754-17757	the	_
107-21	17758-17767	precision	_
107-22	17768-17769	(	_
107-23	17770-17774	i.e.	_
107-24	17775-17776	,	_
107-25	17777-17784	inverse	_
107-26	17785-17795	covariance	_
107-27	17796-17797	)	_
107-28	17798-17804	matrix	_
107-29	17805-17806	.	_

108-1	17807-17820	Incorporating	_
108-2	17821-17825	this	_
108-3	17826-17837	frequentist	_
108-4	17838-17843	prior	_
108-5	17844-17857	automatically	_
108-6	17858-17865	reduces	_
108-7	17866-17869	the	_
108-8	17870-17875	model	_
108-9	17876-17886	complexity	_
108-10	17887-17889	by	_
108-11	17890-17901	identifying	_
108-12	17902-17905	the	_
108-13	17906-17910	most	_
108-14	17911-17920	important	_
108-15	17921-17926	pairs	_
108-16	17927-17929	of	_
108-17	17930-17937	network	_
108-18	17938-17943	nodes	_
108-19	17944-17947	and	_
108-20	17948-17956	ignoring	_
108-21	17957-17960	the	_
108-22	17961-17970	remainder	_
108-23	17971-17972	.	_

109-1	17973-17975	In	_
109-2	17976-17979	the	_
109-3	17980-17984	case	_
109-4	17985-17987	of	_
109-5	17988-17994	graphs	_
109-6	17995-17996	,	_
109-7	17997-18006	selecting	_
109-8	18007-18012	those	_
109-9	18013-18023	covariance	_
109-10	18024-18034	parameters	_
109-11	18035-18037	in	_
109-12	18038-18041	the	_
109-13	18042-18047	space	_
109-14	18048-18050	of	_
109-15	18051-18059	possible	_
109-16	18060-18070	covariance	_
109-17	18071-18077	models	_
109-18	18078-18082	with	_
109-19	18083-18089	sparse	_
109-20	18090-18097	support	_
109-21	18098-18099	(	_
109-22	18100-18104	i.e.	_
109-23	18105-18106	,	_
109-24	18107-18111	many	_
109-25	18112-18123	zero-valued	_
109-26	18124-18134	parameters	_
109-27	18135-18137	in	_
109-28	18138-18141	the	_
109-29	18142-18147	graph	_
109-30	18148-18149	)	_
109-31	18150-18157	equates	_
109-32	18158-18160	to	_
109-33	18161-18169	limiting	_
109-34	18170-18173	the	_
109-35	18174-18180	number	_
109-36	18181-18183	of	_
109-37	18184-18189	graph	_
109-38	18190-18195	edges	_
109-39	18196-18197	.	_

110-1	18198-18202	This	_
110-2	18203-18209	sparse	_
110-3	18210-18215	model	_
110-4	18216-18226	estimation	_
110-5	18227-18240	automatically	_
110-6	18241-18249	balances	_
110-7	18250-18253	the	_
110-8	18254-18264	compromise	_
110-9	18265-18272	between	_
110-10	18273-18280	biasing	_
110-11	18281-18288	towards	_
110-12	18289-18294	model	_
110-13	18295-18305	simplicity	_
110-14	18306-18307	(	_
110-15	18308-18313	hence	_
110-16	18314-18315	,	_
110-17	18316-18331	neurobiological	_
110-18	18332-18348	interpretability	_
110-19	18349-18350	)	_
110-20	18351-18354	and	_
110-21	18355-18364	obtaining	_
110-22	18365-18372	optimal	_
110-23	18373-18378	model	_
110-24	18379-18383	fits	_
110-25	18384-18386	to	_
110-26	18387-18392	brain	_
110-27	18393-18397	data	_
110-28	18398-18399	.	_

111-1	18400-18403	The	_
111-2	18404-18410	degree	_
111-3	18411-18413	of	_
111-4	18414-18416	ð“1	_
111-5	18417-18429	penalization	_
111-6	18430-18431	,	_
111-7	18432-18442	controlled	_
111-8	18443-18445	by	_
111-9	18446-18449	the	_
111-10	18450-18461	coefficient	_
111-11	18462-18463	Î»	_
111-12	18464-18465	,	_
111-13	18466-18469	was	_
111-14	18470-18479	evaluated	_
111-15	18480-18483	and	_
111-16	18484-18492	selected	_
111-17	18493-18495	in	_
111-18	18496-18499	the	_
111-19	18500-18516	cross-validation	_
111-20	18517-18526	procedure	_
111-21	18527-18528	.	_

112-1	18529-18532	One	_
112-2	18533-18542	important	_
112-3	18543-18554	consequence	_
112-4	18555-18557	of	_
112-5	18558-18560	ð“1	_
112-6	18561-18573	penalization	_
112-7	18574-18576	is	_
112-8	18577-18581	that	_
112-9	18582-18591	searching	_
112-10	18592-18595	the	_
112-11	18596-18606	covariance	_
112-12	18607-18616	structure	_
112-13	18617-18624	reduces	_
112-14	18625-18627	to	_
112-15	18628-18629	a	_
112-16	18630-18636	convex	_
112-17	18637-18644	problem	_
112-18	18645-18649	with	_
112-19	18650-18651	a	_
112-20	18652-18658	unique	_
112-21	18659-18667	solution	_
112-22	18668-18669	.	_

113-1	18670-18675	Hence	_
113-2	18676-18677	,	_
113-3	18678-18687	rerunning	_
113-4	18688-18691	the	_
113-5	18692-18698	sparse	_
113-6	18699-18706	inverse	_
113-7	18707-18717	covariance	_
113-8	18718-18728	estimation	_
113-9	18729-18733	with	_
113-10	18734-18743	different	_
113-11	18744-18750	random	_
113-12	18751-18766	initializations	_
113-13	18767-18769	of	_
113-14	18770-18773	the	_
113-15	18774-18779	model	_
113-16	18780-18790	parameters	_
113-17	18791-18795	will	_
113-18	18796-18801	yield	_
113-19	18802-18804	an	_
113-20	18805-18814	identical	_
113-21	18815-18823	solution	_
113-22	18824-18828	each	_
113-23	18829-18833	time	_
113-24	18834-18835	.	_

114-1	18836-18838	In	_
114-2	18839-18842	sum	_
114-3	18843-18844	,	_
114-4	18845-18853	detailed	_
114-5	18854-18867	probabilistic	_
114-6	18868-18874	models	_
114-7	18875-18877	of	_
114-8	18878-18885	network	_
114-9	18886-18894	coupling	_
114-10	18895-18899	were	_
114-11	18900-18913	automatically	_
114-12	18914-18921	derived	_
114-13	18922-18926	from	_
114-14	18927-18937	multi-site	_
114-15	18938-18943	brain	_
114-16	18944-18948	data	_
114-17	18949-18951	by	_
114-18	18952-18957	using	_
114-19	18958-18964	sparse	_
114-20	18965-18972	inverse	_
114-21	18973-18983	covariance	_
114-22	18984-18994	estimation	_
114-23	18995-18997	in	_
114-24	18998-19002	both	_
114-25	19003-19009	groups	_
114-26	19010-19011	(	_
114-27	19012-19016	i.e.	_
114-28	19017-19018	,	_
114-29	19019-19026	healthy	_
114-30	19027-19035	subjects	_
114-31	19036-19039	and	_
114-32	19040-19048	patients	_
114-33	19049-19053	with	_
114-34	19054-19067	schizophrenia	_
114-35	19068-19069	)	_
114-36	19070-19071	.	_

115-1	19072-19078	Models	_
115-2	19079-19086	derived	_
115-3	19087-19091	from	_
115-4	19092-19096	RSFC	_
115-5	19097-19101	data	_
115-6	19102-19107	could	_
115-7	19108-19110	be	_
115-8	19111-19122	interpreted	_
115-9	19123-19125	as	_
115-10	19126-19137	summarizing	_
115-11	19138-19141	the	_
115-12	19142-19146	most	_
115-13	19147-19156	important	_
115-14	19157-19167	functional	_
115-15	19168-19179	connections	_
115-16	19180-19181	,	_
115-17	19182-19187	while	_
115-18	19188-19194	models	_
115-19	19195-19202	derived	_
115-20	19203-19207	from	_
115-21	19208-19211	VBM	_
115-22	19212-19216	data	_
115-23	19217-19222	could	_
115-24	19223-19225	be	_
115-25	19226-19237	interpreted	_
115-26	19238-19240	as	_
115-27	19241-19252	summarizing	_
115-28	19253-19256	the	_
115-29	19257-19261	most	_
115-30	19262-19271	important	_
115-31	19272-19282	volumetric	_
115-32	19283-19296	co-occurrence	_
115-33	19297-19298	.	_

116-1	19299-19306	Testing	_
116-2	19307-19310	for	_
116-3	19311-19322	significant	_
116-4	19323-19334	disturbance	_
116-5	19335-19337	in	_
116-6	19338-19341	DMN	_
116-7	19342-19353	covariation	_
116-8	19354-19360	Sparse	_
116-9	19361-19368	inverse	_
116-10	19369-19379	covariance	_
116-11	19380-19390	estimation	_
116-12	19391-19396	based	_
116-13	19397-19399	on	_
116-14	19400-19404	RSFC	_
116-15	19405-19408	and	_
116-16	19409-19419	separately	_
116-17	19420-19422	on	_
116-18	19423-19426	VBM	_
116-19	19427-19430	was	_
116-20	19431-19433	to	_
116-21	19434-19436	be	_
116-22	19437-19446	conducted	_
116-23	19447-19457	separately	_
116-24	19458-19460	in	_
116-25	19461-19464	the	_
116-26	19465-19472	healthy	_
116-27	19473-19478	group	_
116-28	19479-19482	and	_
116-29	19483-19486	the	_
116-30	19487-19492	group	_
116-31	19493-19495	of	_
116-32	19496-19504	patients	_
116-33	19505-19509	with	_
116-34	19510-19523	schizophrenia	_
116-35	19524-19525	.	_

117-1	19526-19534	Separate	_
117-2	19535-19544	precision	_
117-3	19545-19553	matrices	_
117-4	19554-19558	were	_
117-5	19559-19563	thus	_
117-6	19564-19572	obtained	_
117-7	19573-19575	in	_
117-8	19576-19582	normal	_
117-9	19583-19591	controls	_
117-10	19592-19595	and	_
117-11	19596-19602	people	_
117-12	19603-19607	with	_
117-13	19608-19621	schizophrenia	_
117-14	19622-19623	.	_

118-1	19624-19635	Statistical	_
118-2	19636-19648	significance	_
118-3	19649-19652	for	_
118-4	19653-19658	group	_
118-5	19659-19670	differences	_
118-6	19671-19672	(	_
118-7	19673-19676	Fig	_
118-8	19677-19678	.	_

119-1	19679-19681	2D	_
119-2	19682-19683	)	_
119-3	19684-19687	was	_
119-4	19688-19696	assessed	_
119-5	19697-19702	based	_
119-6	19703-19705	on	_
119-7	19706-19707	(	_
119-8	19708-19719	family-wise	_
119-9	19720-19725	error	_
119-10	19726-19727	,	_
119-11	19728-19747	multiple-comparison	_
119-12	19748-19757	corrected	_
119-13	19758-19759	)	_
119-14	19760-19768	p-values	_
119-15	19769-19772	for	_
119-16	19773-19776	the	_
119-17	19777-19789	multivariate	_
119-18	19790-19793	DMN	_
119-19	19794-19805	covariation	_
119-20	19806-19811	based	_
119-21	19812-19814	on	_
119-22	19815-19828	bootstrapping	_
119-23	19829-19832	for	_
119-24	19833-19847	non-parametric	_
119-25	19848-19858	hypothesis	_
119-26	19859-19866	testing	_
119-27	19867-19868	.	_

120-1	19869-19870	A	_
120-2	19871-19877	series	_
120-3	19878-19880	of	_
120-4	19881-19890	bootstrap	_
120-5	19891-19898	samples	_
120-6	19899-19900	(	_
120-7	19901-19907	n=1000	_
120-8	19908-19909	)	_
120-9	19910-19914	were	_
120-10	19915-19920	drawn	_
120-11	19921-19925	with	_
120-12	19926-19937	replacement	_
120-13	19938-19942	from	_
120-14	19943-19946	the	_
120-15	19947-19954	healthy	_
120-16	19955-19960	brain	_
120-17	19961-19965	data	_
120-18	19966-19967	(	_
120-19	19968-19972	i.e.	_
120-20	19973-19974	,	_
120-21	19975-19979	RSFC	_
120-22	19980-19984	data	_
120-23	19985-19988	for	_
120-24	19989-19999	functional	_
120-25	20000-20012	connectivity	_
120-26	20013-20016	and	_
120-27	20017-20020	VBM	_
120-28	20021-20025	data	_
120-29	20026-20029	for	_
120-30	20030-20033	the	_
120-31	20034-20044	volumetric	_
120-32	20045-20058	co-occurrence	_
120-33	20059-20060	)	_
120-34	20061-20062	.	_

121-1	20063-20066	For	_
121-2	20067-20071	each	_
121-3	20072-20074	of	_
121-4	20075-20078	the	_
121-5	20079-20083	thus	_
121-6	20084-20093	generated	_
121-7	20094-20098	1000	_
121-8	20099-20110	alternative	_
121-9	20111-20118	dataset	_
121-10	20119-20131	realizations	_
121-11	20132-20133	,	_
121-12	20134-20136	we	_
121-13	20137-20146	performed	_
121-14	20147-20150	all	_
121-15	20151-20156	above	_
121-16	20157-20162	steps	_
121-17	20163-20165	of	_
121-18	20166-20169	the	_
121-19	20170-20176	sparse	_
121-20	20177-20184	inverse	_
121-21	20185-20195	covariance	_
121-22	20196-20206	estimation	_
121-23	20207-20208	.	_

122-1	20209-20213	This	_
122-2	20214-20225	computation	_
122-3	20226-20235	generated	_
122-4	20236-20237	a	_
122-5	20238-20242	null	_
122-6	20243-20255	distribution	_
122-7	20256-20258	of	_
122-8	20259-20267	possible	_
122-9	20268-20279	covariation	_
122-10	20280-20289	estimates	_
122-11	20290-20293	for	_
122-12	20294-20299	every	_
122-13	20300-20307	ROI-ROI	_
122-14	20308-20316	relation	_
122-15	20317-20319	in	_
122-16	20320-20327	healthy	_
122-17	20328-20339	individuals	_
122-18	20340-20341	.	_

123-1	20342-20355	Bootstrapping	_
123-2	20356-20360	thus	_
123-3	20361-20369	provided	_
123-4	20370-20378	interval	_
123-5	20379-20388	estimates	_
123-6	20389-20393	that	_
123-7	20394-20403	indicated	_
123-8	20404-20407	how	_
123-9	20408-20412	each	_
123-10	20413-20421	coupling	_
123-11	20422-20430	strength	_
123-12	20431-20433	of	_
123-13	20434-20437	the	_
123-14	20438-20441	DMN	_
123-15	20442-20445	was	_
123-16	20446-20454	expected	_
123-17	20455-20457	to	_
123-18	20458-20460	be	_
123-19	20461-20472	distributed	_
123-20	20473-20475	in	_
123-21	20476-20479	the	_
123-22	20480-20487	general	_
123-23	20488-20498	population	_
123-24	20499-20500	.	_

124-1	20501-20514	Statistically	_
124-2	20515-20526	significant	_
124-3	20527-20538	differences	_
124-4	20539-20546	between	_
124-5	20547-20550	the	_
124-6	20551-20558	healthy	_
124-7	20559-20564	group	_
124-8	20565-20568	and	_
124-9	20569-20572	the	_
124-10	20573-20578	group	_
124-11	20579-20581	of	_
124-12	20582-20590	patients	_
124-13	20591-20595	with	_
124-14	20596-20609	schizophrenia	_
124-15	20610-20614	were	_
124-16	20615-20619	then	_
124-17	20620-20626	tested	_
124-18	20627-20629	at	_
124-19	20630-20633	the	_
124-20	20634-20643	threshold	_
124-21	20644-20657	corresponding	_
124-22	20658-20660	to	_
124-23	20661-20662	p	_
124-24	20663-20664	<	_
124-25	20665-20670	0.001	_
124-26	20671-20673	by	_
124-27	20674-20683	assessing	_
124-28	20684-20691	whether	_
124-29	20692-20695	the	_
124-30	20696-20700	true	_
124-31	20701-20709	coupling	_
124-32	20710-20718	strength	_
124-33	20719-20721	in	_
124-34	20722-20733	individuals	_
124-35	20734-20738	with	_
124-36	20739-20752	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
124-37	20753-20756	was	_
124-38	20757-20763	higher	_
124-39	20764-20766	or	_
124-40	20767-20772	lower	_
124-41	20773-20777	than	_
124-42	20778-20782	99.9	_
124-43	20783-20784	%	_
124-44	20785-20787	of	_
124-45	20788-20791	the	_
124-46	20792-20800	coupling	_
124-47	20801-20810	strengths	_
124-48	20811-20813	in	_
124-49	20814-20817	the	_
124-50	20818-20825	healthy	_
124-51	20826-20836	population	_
124-52	20837-20838	.	_

125-1	20839-20843	Note	_
125-2	20844-20848	that	_
125-3	20849-20850	,	_
125-4	20851-20853	in	_
125-5	20854-20857	VBM	_
125-6	20858-20862	data	_
125-7	20863-20864	,	_
125-8	20865-20867	we	_
125-9	20868-20872	have	_
125-10	20873-20880	applied	_
125-11	20881-20882	a	_
125-12	20883-20887	more	_
125-13	20888-20895	lenient	_
125-14	20896-20905	threshold	_
125-15	20906-20919	corresponding	_
125-16	20920-20922	to	_
125-17	20923-20924	p	_
125-18	20925-20926	<	_
125-19	20927-20931	0.05	_
125-20	20932-20933	,	_
125-21	20934-20939	which	_
125-22	20940-20943	led	_
125-23	20944-20946	to	_
125-24	20947-20958	statistical	_
125-25	20959-20971	significance	_
125-26	20972-20976	when	_
125-27	20977-20987	structural	_
125-28	20988-20999	covariation	_
125-29	21000-21002	in	_
125-30	21003-21016	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
125-31	21017-21025	exceeded	_
125-32	21026-21029	the	_
125-33	21030-21037	healthy	_
125-34	21038-21050	distribution	_
125-35	21051-21053	in	_
125-36	21054-21056	95	_
125-37	21057-21058	%	_
125-38	21059-21061	of	_
125-39	21062-21065	the	_
125-40	21066-21075	bootstrap	_
125-41	21076-21083	samples	_
125-42	21084-21085	.	_

126-1	21086-21090	This	_
126-2	21091-21093	is	_
126-3	21094-21101	because	_
126-4	21102-21105	the	_
126-5	21106-21109	VBM	_
126-6	21110-21118	analyses	_
126-7	21119-21123	were	_
126-8	21124-21133	performed	_
126-9	21134-21136	in	_
126-10	21137-21138	a	_
126-11	21139-21151	small-sample	_
126-12	21152-21160	scenario	_
126-13	21161-21162	(	_
126-14	21163-21167	i.e.	_
126-15	21168-21169	,	_
126-16	21170-21172	as	_
126-17	21173-21177	many	_
126-18	21178-21183	brain	_
126-19	21184-21190	images	_
126-20	21191-21193	as	_
126-21	21194-21206	participants	_
126-22	21207-21208	)	_
126-23	21209-21210	,	_
126-24	21211-21218	whereas	_
126-25	21219-21222	the	_
126-26	21223-21227	RSFC	_
126-27	21228-21236	analyses	_
126-28	21237-21241	were	_
126-29	21242-21251	performed	_
126-30	21252-21254	in	_
126-31	21255-21256	a	_
126-32	21257-21269	large-sample	_
126-33	21270-21278	scenario	_
126-34	21279-21280	(	_
126-35	21281-21285	i.e.	_
126-36	21286-21287	,	_
126-37	21288-21292	tens	_
126-38	21293-21295	of	_
126-39	21296-21305	thousands	_
126-40	21306-21308	of	_
126-41	21309-21314	brain	_
126-42	21315-21321	images	_
126-43	21322-21323	)	_
126-44	21324-21325	.	_

127-1	21326-21328	In	_
127-2	21329-21331	so	_
127-3	21332-21337	doing	_
127-4	21338-21350	significance	_
127-5	21351-21358	testing	_
127-6	21359-21362	for	_
127-7	21363-21368	group	_
127-8	21369-21380	differences	_
127-9	21381-21382	,	_
127-10	21383-21388	first	_
127-11	21389-21391	in	_
127-12	21392-21395	the	_
127-13	21396-21406	functional	_
127-14	21407-21418	covariation	_
127-15	21419-21422	and	_
127-16	21423-21427	then	_
127-17	21428-21430	in	_
127-18	21431-21434	the	_
127-19	21435-21445	structural	_
127-20	21446-21457	covariation	_
127-21	21458-21459	,	_
127-22	21460-21463	has	_
127-23	21464-21468	been	_
127-24	21469-21479	explicitly	_
127-25	21480-21489	corrected	_
127-26	21490-21493	for	_
127-27	21494-21502	multiple	_
127-28	21503-21510	testing	_
127-29	21511-21512	,	_
127-30	21513-21522	searching	_
127-31	21523-21529	across	_
127-32	21530-21533	all	_
127-33	21534-21537	ROI	_
127-34	21538-21543	pairs	_
127-35	21544-21553	estimated	_
127-36	21554-21555	.	_

